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Abstract
Aldehyde dehydrogenase (ALDH) is an enzyme that regulates differentiation during
pancreatic development, but determining the role of ALDH during endocrine differentiation
is not well defined. The purpose of this study was to characterize transcription factors (TFs)
and putative stem cell surface markers in ALDHhi or ALDHlo populations of the human fetal
pancreas (18-22 weeks of age), and examine their expansion and differentiation in vitro and
in vivo. Cell surface marker analysis demonstrated high co-localization of the stem cell
marker CD133 with ALDHhi cells. ALDHhi cells also contained higher expression of isletassociated TFs and insulin. Expansion of sorted ALDHhi cells resulted in down-regulation of
endocrine TF genes, yet differentiated ALDHhi islet-like clusters partially restored TF
mRNA, but not protein, levels. Sorted cells transplanted into nude mice showed increased
vascularization in ALDHlo fibrin gels. In summary, this study demonstrated that ALDHhi
cells represent an endocrine progenitor pool important for β-cell differentiation.
Key Words: Aldehyde dehydrogenase, CD133, β-cell development, FACS, human fetal
pancreas
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Chapter 1 – Introduction
1.1

Significance of Study

The transplantation of functioning and glucose-sensitive β-cells into type I diabetic
patients has been extensively examined for the restoration of endogenous insulin
secretion and function. Although limited success is seen with transplanting existing donor
islets (Ryan et al. 2002), recent interest has been invested in directed differentiation of
uncommitted stem and progenitor cells towards functioning endocrine cells (D’Amour et
al. 2006). Successfully producing cells that secrete insulin in response to blood glucose
fluctuations requires the detailed examination of factors that give rise to β-cells in vivo.
Once these developmental endocrine precursors have been identified and isolated, they
can be expanded and matured in vitro for further analysis regarding their suitability for
transplantation.
The work examined in this thesis provides insight into a putative stem cell marker,
ALDH, that has been previously characterized in the developing human pancreas, and
shown to influence endocrine cell development during the 1st and 2nd trimesters of
pregnancy (Li et al. 2014). Expression of endocrine-committing transcription factors
during development are also necessary, so the overlap of transcription factors within cells
expressing putative stem markers needs to be determined in order to establish their
suitability for further research addressing β-cell generation. This project contributes to the
field of β-cell development by implementing fluorescence-activated cell sorting (FACS)
for the separation of distinct putative stem cell populations within the human fetal
pancreas. Furthermore, sorted cells are characterized and analyzed both in vitro and in
vivo to determine the functions of the isolated populations.

1.2

Overview of the pancreas and diabetes mellitus

The pancreas is a secretory organ of the digestive system that contains two distinctive
functioning units: the exocrine tissue (~98% of the total pancreas) and endocrine tissue
(~2% of the pancreas). The exocrine portion is composed of acinar cells, which produce
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and release digestive enzymes, and ductal cells, responsible for transporting these
enzymes to the duodenum for the breakdown of the bolus. The endocrine cells are located
within clusters known as the islets of Langerhans, and are heavily vascularized to allow
for the release of glucose-regulating hormones into the blood stream. Islets found within
the pancreas are composed of the following cell types and corresponding secreted
hormones: α-cells (glucagon), β-cells (insulin), δ-cells (somatostatin), γ or PP cells
(pancreatic polypeptide, or PP), and ε-cells (ghrelin). Human and murine islets differ in
the morphology and composition of the islets; while murine islets have a higher
percentage of β-cells that cluster in the center of the islet, human islets have higher
contact between α-cells and β-cells (Brissova et al. 2005, Cabrera et al. 2006). Insulin
production and secretion is critical for lowering glucose in circulation via a biphasic
secretion response from the β-cells. Problems encountered with the reuptake of glucose,
regulated by the glucose transporter class (GLUT) (Wood and Trayhurn. 2003), and
production or secretion of insulin is categorized as diabetes mellitus. This disease
manifests itself as two common diagnoses, type I or type II, based on the pathology of the
disease. Type I diabetes is caused by autoimmune destruction of up to 90% of β-cells in
the pancreas, and patients require an exogenous source of insulin to meet metabolic
demands and avoid ketoacidosis (Shapiro et al. 2000). Type II diabetes is generally
associated with insulin resistance across tissues accompanied by insulin dysfunction in βcells (Masini et al. 2012), resulting in the inability to clear glucose from the circulating
blood stream. These patients are typically able to improve glucose levels by exercise and
diet changes.
In order to restore endogenous insulin production and secretion in type I diabetic patients,
the Edmonton Protocol has been designed (Shapiro et al. 2000). This involves the
transplantation of isolated islets from donor pancreata into the hepatic portal vein of
immunosuppressed patients. Although these patients experience exogenous insulin
dependence for the first year after these procedures, a low supply of cadaveric donors and
transplantation complications due to aged islets from donors (Street et al. 2004) limit the
use of this technique. Because of this, there is interest in investigating the formation of
fully differentiated islets from programmed undifferentiated cells for the treatment of
type I diabetic patients. By generating fully differentiated islets from a source that can
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yield a large number of cells, it can be possible to correct the complications seen using
cadaveric islets. In order to understand the developmental pathway of endocrine cells in
the pancreas, the architecture of islets in vivo and specific factors that give rise to
hormone-producing islet cells must be determined.

1.3

Development of the human fetal pancreas

The architecture of the human pancreas changes dramatically during the course of
development. Fetal age, which is assigned two weeks later than the gestational age
(marked at the beginning of the previous menstrual cycle), will be used throughout this
section to describe pancreatic development. The pancreas first develops between 3 to 4
weeks of fetal age as two separate buds off of the duodenum, labeled the dorsal
pancreatic bud and the ventral pancreatic bud (Piper et al. 2004, Jennings et al. 2013).
The dorsal and ventral pancreatic buds fuse at approximately 7 to 8 weeks of fetal age to
form the single immature pancreas (Piper et al. 2004), and the dorsal duct is normally lost
in favour of the ventral pancreatic duct (Kamisawa. 2004). The pancreatic composition at
7 to 8 weeks of fetal age contains a high percentage of mesenchymal cells, with simple
ductal structures and interspersed epithelial clusters (containing emerging endocrine
cells) scattered throughout the mesenchyme (Lyttle et al. 2008, Sarkar et al. 2008). The
ductal cell marker cytokeratin 19 (CK19) is also expressed throughout the epithelial cell
clusters early in development before expression is restricted to duct-like structures
(Sarkar et al. 2008). Around this time, insulin+ cells are detected in the pancreas, and this
is followed with glucagon+ cells emerging at 7 to 8.5 weeks of fetal age (Piper et al.
2004, Jeon et al. 2009). Somatostatin+ cells are seen as early as 8 to 8.5 weeks of fetal
age, while PP+ cells do not emerge until 10 weeks of fetal age (Piper et al. 2004, Jeon et
al. 2009). Ghrelin+ single cells are present in the pancreas at 11 weeks of fetal age
(Andralojc et al. 2009). The grouping of insulin+ and glucagon+ cells close to one another
is first reported at 10 weeks of fetal age, but prominent endocrine clustering of insulin+
and glucagon+ cells with somatostatin+ and PP+ cells is not observed until 15 weeks of
fetal age (Jeon et al. 2009). Ghrelin+ cells are not observed in the islets until 19 weeks of
fetal age (Andralojc et al. 2009). These developing islets are found close to the ductal
structures, and CK19 expression decreases in islets as they mature; CK19 staining is
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weak in islets from 16 to 22 weeks of fetal age, and islets are completely negative for
CK19 from 22 to 39 weeks of fetal age (Bouwens et al. 1997). Beginning at 8 weeks of
fetal age, staining for vasculature could be seen in proximity to the forming endocrine
cell clusters (Sarkar et al. 2008). These vessels invade islet clusters around 12 weeks of
fetal age (Piper et al. 2004), which is necessary for hormone transport in mature islets.
CEL, an indicator of early acinar cells, first appears in the epithelium at 9 weeks of fetal
age (Sarkar et al. 2008). Lobular cell structures form during 12 to 18 weeks of fetal age
(Adda et al. 1984), yet staining for amylase (an acinar secretory enzyme) emerges later
on in the 2nd trimester of pregnancy (Sarkar et al. 2008). The weight of the human fetal
pancreas increases to approximately 337 mg at 21 weeks of fetal age (compared to 9 mg
at 8 weeks of fetal age), and the masses of islet cells, composed primarily of α-cells and
β-cells, express transcription factors indicative of maturing islets (low NGN3 and high
co-localization of PDX-1 and Insulin) (Lyttle et al. 2008).

1.4

TFs associated with endocrine cell differentiation

Successful commitment to islet and β-cell fate requires sequential expression of
transcription factors during development of the human pancreas (Figure 1.1) (Lyttle et al.
2008). For endocrine cell commitment (and specifically β-cell fate), endoderm cells first
up-regulate transcription factors necessary for pancreas development. PTF1α and PDX-1
are early pancreatic progenitor transcription factors expressed in the developing
pancreatic buds and are required for pancreatic development from the duodenum (Offield
et al. 1996, Kawaguchi et al. 2002, Burlison et al. 2008). SOX9, another pancreatic
progenitor factor found during early development, maintains the progenitor cell pool
during development and plays a prominent role during cell lineage determination via
Notch activity (Lynn et al. 2007, McDonald et al. 2009, Shih et al. 2012). The cell type
that develops from the pancreatic epithelium relies on activation of the Notch receptor,
which increases the precursor transcription factor HES-1 (Apelqvist et al. 1999, Kopinke
et al. 2011). HES-1 inhibits NGN3, the endocrine precursor transcription factor, during
early stages of development (Jensen et al. 2000a and 2000b, Gu et al. 2002, Fujikura et
al. 2006), but decreased Notch activation later on in development leads to expression of
NGN3 (Shih et al. 2012). Once cells are committed to endocrine fate, there is further
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regulation of transcription factor downstream of NGN3 required for islet cell
commitment and function, including PAX6 (Sander et al. 1997), ISL1 (Du et al. 2009),
and NKX6.1 (Schaffer et al. 2013). A detailed description of important transcription
factors examined throughout this project is provided below.

1.4.1

SOX9

SRY (sex determining region Y)-box 9 (SOX9) is part of the high-mobility binding group
domain family, and is recognized as a pancreatic progenitor transcription factor, as well
as a marker of small intestine progenitors (Formeister et al. 2009, Belo et al. 2013). It is
found upstream of key transcription factors responsible for commitment to pancreatic cell
fate, and contributes to the progenitor pool during pancreatic development (Seymour et
al. 2007 and 2012). In the developing human pancreas, strong SOX9 staining is first
present in the immature pancreatic buds 32 days after conception (between 4 to 5 weeks
of fetal age); however SOX9 decreases with age, with a noticeable drop at 17 to18 weeks
of fetal age (McDonald et al. 2012). Although inactivating Sox9 expression in the
pancreas reduces Pdx-1 expression levels, pancreatic tissue still develops (Seymour et al.
2007, Dubois et al. 2011), indicating that multiple TFs are responsible for pancreas
organogenesis. Co-localization of SOX9 with NGN3+, insulin+, and glucagon+ cells is
seen at 8 to 11 weeks of fetal age, but a dramatic loss of SOX9 in these endocrine cells is
observed at 20 to 21 weeks of fetal age (McDonald et al. 2012), indicating that SOX9
contributes to endocrine cell formation during the early stages of fetal development. At
later stages of pancreatic development (20 to 21 weeks of fetal age in human), SOX9+
cells are primarily found in the pancreatic ducts (Shih et al. 2012, McDonald et al. 2012).
This observation correlated with examined adult murine pancreata 8 weeks after birth,
where Sox9 is retained in ductal cells (Furuyama et al. 2011). Sox9 also contributes to the
exocrine compartment, as seen in the developing murine pancreas (Kopp et al. 2011),
indicating that this TF is not restricted to a specific pancreatic cell lineage during
development. Campomelic dysplasia (CD) patients, diagnosed with SOX9
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Figure 1.1 Pathway of transcription factor activation for β-cell induction. The
diagram above is a simplified pathway of β-cell differentiation that focuses on key TF
expression mentioned in this thesis. The information in this figure is modified from
results found in Lyttle et al. (2008), McDonald et al. (2012), and Riedel et al. (2012).
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haploinsufficiency, demonstrate reduced islet cell size and dysfunction, with no
observable effect on the surrounding exocrine tissue (Piper et al. 2002). Therefore, dose
dependent studies have been conducted to focus on this observed effect. Developing
murine pancreata with a ~50% decrease in Sox9 expression supported what is seen in CD
patients, with normal pancreatic organogenesis but reduced islet size and number of
endocrine cell precursors (Seymour et al. 2008). This is further supported by the siRNA
knockdown of SOX9 gene in human fetal islet epithelial cell clusters (~50% reduction in
SOX9), where a significant reduction of NGN3 and Insulin mRNA expression was
observed (McDonald et al. 2012). Overall, these studies indicate that SOX9 is essential
for maintaining the pancreatic progenitor pool and important for regulating the early
development of endocrine islet cells.

1.4.2

PDX-1

Pancreatic and duodenal homeobox 1 (PDX-1) is a transcription factor that is part of the
homeodomain-containing family (Kaneto et al. 2008) and regulates the cell fate of
pancreatic and duodenal cells (Burlison et al. 2008). Although the exocrine transcription
factor Ptf1a is important for endoderm commitment to the pancreatic fate, PDX-1 has
been identified as an important transcription factor for endocrine cell development
(Burlison et al. 2008, Lyttle et al. 2008). It first appears in the developing human
pancreas at approximately 4 weeks of fetal age along the foregut area that is reported as
the precursor to the mature duodenum and pancreas (Jennings et al. 2013). PDX-1 is also
found after the dorsal and ventral buds fuse in the developing human pancreas at 7 weeks
of fetal age (Lyttle et al., 2008, Sarkar et al. 2008). The endocrine, acinar, and ductal cells
of the pancreas all arise from Pdx-1+ cells (Gu et al. 2002), emphasizing the important
role that Pdx-1 plays during normal murine pancreas development. PDX-1 expression is
also necessary in human embryonic stem cells in order to successfully produce endocrine
cells (Johannesson et al. 2009). Furthermore, Pdx-1 expression is seen earlier than Ngn3
expression (Villasenor et al. 2008), indicating its upstream effects on endocrine cell
differentiation. However, PDX-1 and NGN3 co-localization decreases with age in the
developing fetal pancreas (Lyttle et al. 2008), which could represent a progenitor pool
becoming committed to the endocrine cell fate. In addition, PDX-1 co-localization
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decreases in CK19+ cells, increases in insulin+ and somatostatin+ cells, and is not present
in committed glucagon+ cells during human fetal development (Lyttle et al. 2008),
demonstrating specificity of this transcription factor towards distinct endocrine cell fate
in later stages of development.

1.4.3

NGN3

Neurogenin 3 (NGN3) is a basic helix-loop-helix transcription factor (Jensen et al.
2000b) that commits pancreatic cells to the endocrine islet precursor cell fate (Gu et al.
2002, Gradwohl et al. 2000). It is downstream of the Notch receptor, which under normal
circumstance activates the exocrine-promoting transcription factor HES-1 and inhibits
NGN3 expression (Dror et al. 2007). In early stages of human fetal pancreatic
development (8 to 11 weeks of fetal age), NGN3+ cells co-localize frequently with PDX1+, insulin+, and glucagon+ cells; this co-expression decreases in pancreata at later stages
of development (20 to 21 weeks of fetal age) (Lyttle et al. 2008), suggesting an important
role for this factor during early initial endocrine commitment. However, recent
information from human patients with NGN3 biallelic deletions reported that patients still
produced insulin (Rubio-Cabezas et al. 2014). This indicates that there is an alternative
differentiation pathway for insulin-secreting cells that does not require NGN3 expression
early on in human development. Ngn3+ cells in the developing murine pancreas have
been shown to co-localize with Sox9+ ductal cells, demonstrating an endocrine precursor
rich area during development (Lynn et al. 2007). In addition, murine development studies
have identified that Ngn3 is downstream of Pdx-1 (Oliver-Krasinski et al. 2009),
indicating that endocrine cells emerge after initial pancreatic commitment. Further
experiments in murine pancreata confirm a lack of Ngn3 expression in acinar cells during
development, and that Ngn3 was absent from the pancreas of adult mice (Gradwohl et al.
2000).

1.4.4

NKX2.2 and NKX6.1

NK2 homeobox 2 (NKX2.2) is a transcription factor that contributes to endocrine cell
fate. Nkx2.2 is seen throughout the dorsal pancreatic bud in early stage murine embryos,
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but becomes restricted to the endocrine cells in later stage embryos (Sussel et al. 1998).
Murine pancreata analyzed right before birth show that there is high co-localization of
Nkx2.2 with insulin+ and glucagon+ cells, but not somatostatin+ cells (Sussel et al. 1998),
suggesting that Nkx2.2 activity is only necessary for specific endocrine cell development.
Unlike Ngn3, Nkx2.2 is still found within the endocrine cells of the islets in adult murine
pancreata (Sussel et al. 1998), indicating that this transcription factor could be used to
isolate certain mature islet cells. In addition, Nkx2.2 affects β-cell functionality and
insulin secretion in adult murine pancreata (Doyle and Sussel. 2007).
NK6 homeobox 1 (NKX6.1) is another transcription factor of the same homeobox gene
group that is specifically associated with β-cell commitment (Sander et al. 2000).
Research in the embryonic murine pancreas shows that early on in development (e10.5),
Nkx6.1 is found in multipotent cells, and co-localizes with the acinar-committing TF
Ptf1α (Schaffer et al. 2010), before becoming confined to the endocrine-producing area
of the pancreas along the ductal cells after birth (Schaffer et al. 2010, Schaffer et al.
2013). Murine studies have demonstrated that Nkx6.1 is necessary for ensuring β-cell fate
during development, but not other endocrine cell fates, and is not solely sufficient for βcell development (Schaffer et al. 2013). Similar to Nkx2.2, Nkx6.1 is present throughout
the developing pancreas in early stage murine embryos, but becomes restricted to insulin+
and ductal cells in later stages (Sander et al. 2000), before finally becoming β-cell
restricted (Schaffer et al. 2013). Parallel studies in human fetal pancreata found that
NKX6.1 co-localizes with insulin+ cells as early as 10 weeks of fetal age, with adult
pancreata only displaying NKX6.1 co-localization in β-cells (Lyttle et al. 2008, Riedel et
al. 2012).

1.4.5

ISL1

Islet 1 (ISL1) is a transcription factor in the LIM homeodomain family (Ahlgren et al.
1997) that has been linked to both mesenchymal and progenitor cells of the pancreas
(Eberhardt et al. 2006). Isl1 cell expression affects all endocrine cells in the pancreas
(Eberhardt et al. 2006, Andralojc et al. 2009). Embryonic mice with a mutation of Isl1
did not develop mesenchyme in the dorsal portion of the pancreas, and the isolated tissue
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could not produce any of the islet endocrine cells from the epithelial buds (Ahlgren et al.
1997). Additionally, Isl1 is present in islet cells of the adult pancreas and have been
shown to increase proliferation and maintain glucose tolerance in β-cells (Guo et al.
2011, Ediger et al. 2014), revealing that Isl1 modulates islet cells in the adult pancreas
and is not restricted to pancreatic development. Mutations in Isl1 expression reduces
Pax6+ cells in the postnatal murine pancreas, and is responsible for regulating the
transcription of MafA, another transcription factor needed to establish proper glucose
sensing in β-cells (Du et al. 2009).

1.4.6

PAX4 and PAX6

Paired box gene 4 (PAX4) is a transcription factor that, although not analyzed in this
project, is heavily associated with β-cell development. It is directly antagonistic to the αcell transcription factor Arx (Collombat et al. 2003 and 2005), and has been demonstrated
to increase insulin+ cells during differentiation of mESCs programmed with vectors
containing that specific gene (Blyszczuk et al. 2003). Additionally, PAX4 overexpression
in adult rat islets resulted in increased β-cell proliferation (Brun et al. 2004).
Unlike PAX4, Paired box gene 6 (PAX6) is a transcription factor that is associated with
insulin+ and glucagon+ cells during early endocrine cell development (Sander et al. 1997).
However, studies of adult murine pancreata demonstrate that Pax6+ cells are found in all
endocrine cell types and regulates via their hormone gene promoters (Sander et al. 1997).
Pax6 mutant mice do not develop glucagon+ cells and display abnormal islets (St-Onge et
al. 1997), suggesting that PAX6 is important for α-cell development and proper islet cell
formation.

1.5 Pancreatic stem cells and endocrine cell differentiation
The production of new endocrine cells in the pancreas is a debated topic, with evidence
of new adult β-cells arising from replication instead of stem cells as a possible source
(Dor et al. 2004). Therefore, establishing stem cell sources within the pancreas is
important for further understanding islet cell repopulation. Uncommitted progenitor cell
pools are present during pancreatic development and organ maturation, while possible
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pools of stem cells have been reported throughout the adult pancreas. This section will
focus on the developing and adult human pancreas, and will discuss stem cell
contributions to specific pancreatic cell fate.

1.5.1

Stem cell sources in the embryonic and fetal pancreas

The differentiation of immature cells in the fetal pancreas has been studied extensively to
explain the relationship of precursor cells during endocrine cell commitment. Precursor
cells are important for the overall development of the pancreas, as seen in the reduction
of Pdx-1+ multipotent cells during murine development (Stanger et al. 2007). Since the
maturation of the pancreatic tissue occurs throughout organogenesis, pancreatic cells
readily express transcription factors that mark an uncommitted phenotype, including
SOX9, PDX-1, and NKX6.1 (Lyttle et al. 2008, McDonald et al. 2012, Pan and Brissova.
2014); this indicates additional multipotency throughout the developing pancreas than
what is seen in the adult structures. Nevertheless, examining the fetal pancreas for known
stem cell markers (discussed in the following sections) assists with precursor
identification.
Although in vitro stem cells sources do not capture in vivo pancreatic organogenesis, the
use of embryonic stem cells, both human (hESCs) and murine (mESCs), are important
for determining transcription factors and markers that link commitment of the developing
pancreas to specific cell function (Kelly et al. 2011). Committing ESCs to definitive
endoderm, characterized by the successful expression of Pdx-1, allows for accessible
programming of this layer towards different cell fates in vitro (Micallef et al. 2005,
D’Amour et al. 2006, Micallef et al. 2007). Further treatments of Pdx-1+ murine and
human ESCs with stage-dependent protocols, designed to guide undifferentiated cells
towards a committed pancreatic cell fate, have resulted in the production of endocrine
cells in vitro (Jiang et al. 2007, Micallef et al. 2007). Additionally, hESCs geared towards
β-cell fate and composed of a high population of NKX6.1+ cells are able to mature into
insulin-secreting cells in vivo and alleviate diabetic symptoms when transplanted into
STZ mice (Rezania et al. 2013), indicating the functional applications of this stem cell
source.
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1.5.2

Stem cell sources in the adult pancreas

The adult pancreas is a fully matured organ with functioning differentiated cells, though
it has been noted that progenitor sites that contribute to endocrine cell development
during fetal organogenesis lose their ability in the adult pancreas (Solar et al. 2009, Kopp
et al. 2011). As a result, the isolation of cells with progenitor features from this source
has been thoroughly examined to determine if there is an undifferentiated population that
contributes towards the islet cell population. Indeed, adult murine islet and ductal cells
were able to separately form colonies of pancreas-derived multipotent cell clusters
(Seaberg et al. 2004), showing that there is potential for restoring undifferentiated cells in
committed lineages. One identified bulk source is the epithelial compartment of the
pancreas (Hao et al. 2006). Successful isolation of epithelial cells from islet and
mesenchymal cells resulted in the ability to use this population in vitro as a stem cell
source for endocrine cell production (Hao et al. 2006). In contrast, mesenchymal cells
isolated from pancreatic islets expressed ISL1 and were able to form c-peptide-producing
cell clusters under differentiation conditions, indicating that these cells are a pancreatic
source capable of producing endocrine cells (Eberhardt et al. 2006). The ductal
epithelium of the adult pancreas, identified as a progenitor pool in fetal pancreata, may
also represent another source that contributes to new islets (Gao et al. 2003). Cells that
exhibit stem cell traits have been previously isolated from isolated adult human
pancreatic ducts and demonstrated endocrine cell lineage in vitro (Lin et al. 2006).
Furthermore, adult patients suffering from nesidioblastosis are able to generate insulin+
cells from pancreatic ductal cells (Gmyr et al. 2000), demonstrating lineage plasticity and
the potential for β-cell production in vivo. Isolated adult murine ductal cells also display
multipotency when cultured, and demonstrated endocrine transcription factors as well as
guided islet differentiation (Ramiya et al. 2000). Finally, research focused on in vivo
pancreatic duct ligation has been used to examine its effect on endocrine cell production
during pancreatic injury, with supporting (Wang et al. 1995, Van de Casteele et al. 2014)
and contrasting (Kopp et al. 2011, Rankin et al. 2013) evidence regarding the stimulation
of β-cell neogenesis. Ligation drastically amplifies the presence of cells positive for the
stem cell marker c-Kit (CD117) within the ducts (Peters et al. 2005), revealing that
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progenitor cells can be stimulated within this tissue source. Furthermore,
pancreatectomies in adult rats that had the pancreatic tail and most of the pancreatic head
removed led to regeneration of the missing tissue via the ductal epithelium, again
suggesting that the ducts contain progenitor cells capable of endocrine repair (BonnerWeir et al. 1993). The acinar cells from the exocrine portion of the pancreas have also
demonstrated precursor features, as seen during the transdifferentiation of acinar-toductal cells in vitro and the subsequent appearance of PDX-1, necessary for the early
stages of islet commitment (Rooman et al. 2000). An additional cell source that has been
reported is the pancreatic stellate cell (PSC) (Kordes et al. 2012, Lonardo et al. 2012),
which can be located throughout the pancreas around the ductal cells (Apte et al. 2012),
and can also be isolated from pancreatic tumours (Lonardo et al. 2012).
Identifying multipotent cells within the developing pancreas is ideal for understanding
the organogenesis of hormone-producing islet cells and can be utilized for
reprogramming stem cells from multiple sources into β-cells. For the proper isolation of
potential pancreatic islet progenitor cells that could be differentiate into islet cells, select
surface stem cell markers must also be established.

1.6 Surface stem cell markers
Surface proteins located on the outer cell membrane are useful for isolating viable stem
and progenitor cells by FACS for further analysis, since they can be tagged with
antibodies without jeopardizing cell population. The clusters of differentiation (CD)
markers are located on the outer membrane of cells and are commonly identified on
hematopoietic stem and progenitor cells (Yin et al. 1997), and as a result this cell type is
often studied for differentiation and regeneration properties. This project focused on the
following three CD markers: CD133, CD34, and CD117 (Figure 1.2).

14

Figure 1.2 The presence of surface stem cell markers in the pancreas. CD133, CD34,
and CD117 are not specific for one pancreatic cell lineage, and are found on multiple cell
types throughout the development of pancreas. This figure is a summary of the studies
described in Section 1.6, and encompasses human and murine pancreatic development
and analysis studies.
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1.6.1

CD133

CD133 (also known as Prominin-1) is a pentaspan membrane protein surface marker
found on multiple cell types, including the tubular cells of the kidneys (Lindgren et al
2011), the cells of the retina (Zacchigna et al. 2009), and on hematopoietic progenitor
cells from different cell sources (Hess et al. 2006, Barraud et al. 2007, Snippert et al.
2009). It is also heavily associated with different forms of neoplastic cells and has been
examined alongside ALDH to characterize and determine tumour aggressiveness
(Alamgeer et al. 2013, Zhou et al. 2014). In addition, CD133 has recently been defined as
an important proponent of epithelial-to-mesenchymal transition (EMT) and migration in
neoplastic cells (Ding et al. 2012). CD133 levels in mESC are affected by the cell’s
progression towards mature differentiation, where high levels were seen in cells that were
committed but not yet differentiated (Kania et al. 2005). The expression of CD133 in the
pancreas is strongly associated with ductal epithelial cells (Oshima et al. 2007, Lardon et
al. 2008, Koblas et al. 2008, Rovira et al. 2010), and transdifferentiation of acinar cells to
a ductal cell fate resulted in increased CD133 expression (Houbracken et al. 2011). The
early stage human fetal pancreas has been reported to express CD133 on epithelial cells
(Zhang et al. 2013), and this has also been reported in the developing murine pancreata
(Hori et al. 2008). Additionally, pancreatic stellate cells (PSCs) and endothelial cells have
been reported to express CD133 (Koblas et al. 2008, Kordes et al. 2012). Cells that
express this marker on their surface have also been described as a precursor population
for β-cells (Skurikhin et al. 2014). CD133 is present on the surface of Pdx-1+ epithelia in
developing murine embryos (Hori et al. 2008), and ductal CD133+ cells in the human and
murine fetal pancreas co-localize with NGN3 at 14 weeks of age (Sugiyama et al. 2007),
demonstrating an endocrine precursor fate of this cell type. Expanded cells from human
umbilical cord blood that are CD133+ also co-express PDX-1 and NGN3 (Pessina et al.
2010), showing the potential for non-pancreatic CD133+ cells to differentiate into isletlike cells. The contributions of CD133+ cells in giving rise to different cell fates in the
pancreas may be age restricted, since there have been reports that adult murine pancreata
have higher expression of acinar and endocrine cell in CD133- populations, and that
ductal fate is propagated in CD133+ cells (Jin et al. 2013). In addition, adult human
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pancreas cells that express CD133 do not co-localize with the stem cell markers OCT4 or
SOX2 (Zhao et al. 2007), suggesting that CD133+ cells at this stage are associated more
with mature ductal epithelium.

1.6.2

CD34

CD34 is a transmembrane protein (Simmons et al. 1992), and is most frequently
associated with being a marker of hematopoietic stem cells (Ito et al. 2000, Hess et al.
2004). The multipotency of this stem cell marker has been extensively researched; CD34
cells have demonstrated the ability to reconstitute hematopoiesis and aid in the recovery
of damaged tissue (Iwasaki et al. 2006). Although it is not commonly associated with the
pancreas, the presence of CD34 has been previously examined throughout the tissue.
Cells close to the ductal cells of the rat pancreas showed CD34 expression, and CD34
was seen dispersed throughout the islet (Joanette et al. 2004). CD34 has also been
identified on fibrocytes surrounding the ductal and acinar cells of the adult human
pancreas (Barth et al. 2002). It has also been identified as a marker of developing
vasculature in the islets of the human fetal pancreas (Piper et al. 2004) and in the
mesenchymal tissue early on in development (Castaing et al. 2005). In the bovine
pancreas, CD34 is present on α- cells of the islets (Merkwitz et al. 2011). Although CD34
is recognized as a marker for hematopoietic stem cells, there was no co-localization seen
in cells expressing the stem cell markers SOX2 or OCT4 in the adult pancreas (Zhao et
al. 2007). However, CD34+ hESCs transplanted into sheep were able to provide higher
levels of circulating human c-peptide than populations with heterogeneous cell
expression (Goodrich et al. 2010), demonstrating that CD34+ hESCs have the potential to
give rise to insulin-producing cell-like fate.

1.6.3

CD117

CD117 is a receptor tyrosine kinase found in progenitor cells from multiple sources,
including bone marrow-derived hematopoietic cells (Wodja et al. 2003), bone marrow
cells (Hess et al. 2003), and in tumour cell populations (Pietsch et al. 1998). Furthermore,
CD117 is associated with endoderm cell commitment in precursor hESCs (Cheng et al.

17

2012). The ligand of CD117 is stem cell factor (SCF), and SCF plays an important role
for increasing endocrine expression in the human fetal pancreas (Li et al. 2006). In the rat
pancreas, CD117 has been isolated in cells close to the ducts and within the islets
(Joanette et al. 2004, Wang et al. 2004). Further examination of the islet populations
showed that rat epithelial monolayers expanded from isolated islets on collagen I gels,
contained an increased number of proliferating CD117-expressing cells with constant
expression of Pdx-1, Ngn3, Pax4, and multiple undifferentiated cell markers, including
Oct4 and α-fetoprotein (Wang et al. 2004). Islet-like clusters with increased insulin+ and
glucagon+ cells were formed from the monolayer when cultured on laminin-rich matrigel,
and the cells secreted insulin in response to glucose (Wang et al. 2004). In a pancreatic
duct ligation model, the ligated portion showed an increase of CD117+ cells in ductal and
islet cells with increased Pdx-1 and CD117 co-localization (Peters et al. 2005), indicating
possible pancreatic regeneration from a progenitor cell source. In the human fetal
pancreas, CD117 expression in the ductal cells decreased with age, but co-localized with
insulin+ and glucagon+ cells and remained consistent in islet cells (Li et al. 2007). Similar
to human pancreata, the expression of CD117 drops in the islets, acinar, and ductal cells
of postnatal rats after birth, with the majority of CD117 cells surrounding the islet
(Yashpal et al. 2004). Murine pancreata during later stages of embryonic development
showed high co-localization of CD117 with Ngn3 and insulin (Ma et al. 2012). In parallel
to murine development, exogenous activation of CD117 in the human fetal pancreas
leads to increased PDX-1 and insulin protein expression (Li et al. 2007). Further
examination of CD117 revealed that reduction of CD117 in PANC-1 cells (a human
pancreatic epithelial cancer cell line) led to decreased PDX-1 and insulin expression (Wu
et al. 2010). Similar to CD34, mesenchymal cells isolated from human placenta express
CD117; these cells were able to differentiate into islet-like clusters in vivo and
demonstrated successful insulin production (Kadam et al. 2010). The transplantation of
murine bone marrow-isolated CD117+ cells into STZ mice reduced circulating blood
glucose, and even outperformed larger cell transplantation populations of CD117- cells
(Hess et al. 2003). Overall, previous works examining CD117 suggest that it is an
important marker for β-cell differentiation and regeneration.

18

1.6.4

Additional surface stem cell markers

Alongside the surface markers listed above, additional cell surface markers have recently
been studied and identified as indicators for pancreatic cell fate. CD24 cells highly coexpress PDX-1 in definitive endoderm hESCs, and have the capacity to differentiate into
insulin-producing cells compared to cells that do not express this surface marker (Jiang et
al. 2011). It is important to note that the exclusivity of the CD24 marker to PDX-1 cells
has been challenged in repeated hESC experiments, where CD24 was also present on
cells that did not stain for PDX-1 (Naujok and Lenzen. 2012). Stage-specific embryonic
antigen 4 (SSEA4) is another novel progenitor marker that can be found in cells
surrounding the endocrine cells of the pancreas (Afrikanova et al. 2012). It co-localizes
with CD133 in the adult human pancreas and NGN3 in the fetal human pancreas
(Afrikanova et al. 2012). c-Met, like CD117, is another receptor tyrosine kinase (Bladt et
al. 1995) that is found in small percentages on the acinar and ductal cells of the
developing murine pancreas (Suzuki et al. 2004).

1.7 Aldehyde Dehydrogenase
Although cell surface markers are frequently used to identify stem cells, intracellular
markers have also been examined. Aldehyde dehydrogenase (ALDH) is an NAD+
dependent enzyme (Hammen et al. 2002) found in the cytosol and mitochondria of cells
in many different vertebrae (Jackson et al. 2011). It has been detected in various tissue
types, including the endoderm-derived liver (Kiefer et al. 2012), lung (Hind et al. 2002),
and stomach (Yin et al. 1988). ALDH is also currently regarded as a useful marker for
identifying stem cells in normal and malignant tissue populations. As a result, recent
research regarding ALDH has focused on its potential as a stem cell marker.

1.7.1

The ALDH family and Retinoic Acid

The 19 isoforms of ALDH are grouped within the families ALDH1 (1A1, 1A2, 1A3,
1B1, 1L1, 1L2), ALDH2, ALDH3 (3A1, 3A2, 3B1, 3B2), ALDH4 (4A1), ALDH5
(5A1), ALDH6 (6A1), ALDH7 (7A1), ALDH8 (8A1), ALDH9 (9A1), ALDH16 (16A1),
and ALDH18 (18A1) (Jackson et al. 2011). Cytosolic ALDH isoforms found within the
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ALDH1 class are responsible for retinoic acid conversion from retinaldehyde (Marchitti
et al. 2008), and are subsequently known as the retinaldehyde dehydrogenase (RALDH)
class (Niederreither et al. 2002) (Figure 1.3). They can affect the production of retinoic
acid in the developing system, as seen in mice with ALDH1a1 deletions and stunted
retinoic acid conversion (Molotkov and Duester. 2003).
Retinoic acid (RA), the product of the retinaldehyde dehydrogenase class, can induce
differentiation towards specific cell fate (Andrews. 1984, Wobus et al. 1997, Cai et al.
2010), and can induce multipotent stem cells towards pancreatic cell fate (Micallef et al.
2005). Retinoic acid regulates two different types of receptors, the retinoic acid receptors
(RAR) and the retinoid X receptors (RXR). Retinoic acid stimulates RAR-RXR dimer
formation and binding of the dimer to DNA (Rastinejad et al. 2000), affecting the
expression of retinoic acid response elements (Glass et al. 1991) and regulating gene
transcription (Li et al. 2014). All-trans retinoic acid (ATRA) is one isoform of retinoic
acid found to affect embryonic development (Klug et al. 1989). It binds to the RAR
group, but has low affinity for RXR binding (Heyman et al. 1992). 9-cis retinoic acid (9cis RA) is another retinoic acid isomer similar to ATRA, but has the ability to bind to
RAR and RXR sites (Heyman et al. 1992). Consistent treatment of ALDH1-expressing
cells with ATRA and 9-cis RA demonstrated dose-dependent down-regulation of ALDH
(Moreb et al. 2005), indicating that sufficient production of RA can lead to downregulation of its producing enzyme. Diethylaminobenzaldehyde (DEAB) is the major
reversible inhibitor associated with halting ALDH activity (Russo et al. 1995) (Figure
1.3), and its actions have been demonstrated across multiple isoforms of ALDH (Moreb
et al. 2012).

1.7.2

ALDH and its use as a stem cell marker

Primary cells with ALDH activity display characteristics associated with stem cells,
including the ability to promote self-renew via proliferative capacity and differentiation
towards to other cell types (Ginestier et al. 2007, Burger et al. 2009). As such, ALDH
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Figure 1.3 Retinoic acid in cell differentiation and proliferation. Inhibition of retinoic
acid production with DEAB treatment prevents differentiation of cells, but is reversed
with exogenous retinoic acid treatment. The dimerization of RAR-RXR regulates TF
expression, and stimulates cell proliferation and differentiation. Modified from Li et al.
(2014).
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has extensively been examined in different tissues and in vitro stem cell sources to further
elucidate its role in multipotent cell fate (Corti et al. 2006). ALDH-expressing cells
isolated from tissue demonstrated the ability to form replicating spheres in vitro, which
retained the stem cell property of self-renewal (Ginestier et al. 2007, Lindgren et al. 2011,
Li et al. 2010). In contrast, the inhibition of ALDH via DEAB has been linked to halting
differentiation, illustrating the regulatory role of ALDH in multipotent populations. This
was seen in hematopoietic stem cells that had been exposed to DEAB, where it resulted
in an extension to their immature progenitor state (Muramoto et al. 2010). ATRA
treatment has been found to rescue DEAB-inhibited cell populations and lead to
differentiation (Figure 1.3) (Chute et al. 2006, Muramoto et al. 2010, Li et al. 2014),
suggesting that while ALDH can serve as an identifying factor of stem cells, it is
important for driving cell differentiation via regulation of retinoic acid. The retinoic acidproducing isoform Aldh1a1 is highly expressed in murine hematopoietic stem cells, but
its deficiency in mice does not affect the function of this stem cell population (Levi et al.
2009). This suggests that although ALDH is an important factor in stem cells, it is not the
sole regulator of stem and progenitor cells.
The relationship between ALDH and other markers of stem cell fate has also been
demonstrated in different types of stem cells, aiding in the isolation of multipotent cells
by using stem cell-associated markers to further characterize ALDH cell populations
(Hess et al. 2004, Burger et al. 2009). Cells positive for the SSEA4 marker express higher
levels of the ALDH1A1 isoform than SSEA4 negative cells in the developing human
pancreas (Afrikanova et al. 2012), and in the adult murine pancreas, isolated ALDH+
cells that co-localize highly with the CD133 surface marker showed the ability to
differentiate into multiple pancreatic cell types (Rovira et al. 2010). This establishes that
by pairing the expression of stem cell markers with high ALDH activity in tissue, it may
be possible to precisely isolate cells that display regenerative capabilities. However,
previous research has shown variations, with hematopoietic stem cell studies
demonstrating the presence (Storms et al. 2005) and absence (Armstrong et al. 2004) of
the CD34 marker on ALDH+ populations, emphasizing the complexity of using ALDH
co-localization studies for stem cell identification.

22

Although the presence of ALDH can indicate a normal stem cell population, stem cells
found in cancerous tissue also express ALDH and have subsequently led to multiple
papers examining this enzyme. It is important to note that ALDH does not serve as a
guaranteed marker for cancerous cells; cells with low ALDH expression have also
demonstrated neoplastic properties in vivo (Prasmickaite et al. 2010), agreeing with
developmental studies that show multiple markers that indicate stem cell multipotency.
ALDH1 is high in cancers affecting many endoderm-derived tissues, including the
pancreas, and has been linked to poor patient survival rates (Deng et al. 2010). In addition
to this, the activity of ALDH in tumour tissue has been linked to chemotherapy drug
resistance (Croker and Allan. 2012).

1.8 The Role of ALDH and RA in Pancreatic Development
and Function
Current research examining pancreatic development has found that ALDH and its
associated receptors can alter the cell composition of an organ. The ALDH1A1 isoform
has been identified as the form that makes up a large majority of ALDHhi pancreatic cells
in both fetal (Li et al. 2014) and adult human pancreata (Chiang et al. 2009). Both RAR
and RXR have been detected in the pancreas during embryonic murine formation, with
isoform expression varying in different regions of the pancreas (Kadison et al. 2001,
Kobayashi et al. 2002), indicating that there is ATRA and 9-cisRA activity during
development (Kane et al. 2010). A summary can be found in Figure 1.4.

1.8.1

Endocrine Fate and the Formation of Islet Cells

The ALDH1 family affects endocrine cells within the developing pancreas. Analysis of
ALDH1 activity in the developing human fetal pancreas was extensively examined in our
laboratory (Li et al. 2014), and the findings will be covered in brief below. Although
overall ALDH activity decreased in the developing human pancreas late in the 2nd
trimester of pregnancy, the retinaldehyde dehydrogenase isoform ALDH1A1 level
increased as pancreas development progressed (Li et al. 2014), indicating an important
developmental role for retinoic acid during late development. Along with these findings,
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Figure 1.4 Generation of pancreatic cell lineages with retinoic acid treatment.
Differentiation studies reveal that the application of retinoic acid promotes the
proliferation of specific pancreatic cell lineages while repressing others. Summarized
from the references in Section 1.8.
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ALDH1 cells highly co-localized (~90%) with SOX9, PDX-1, and NGN3 (Li et al.
2014), and transcription factors downstream of NGN3 (NKX6.1, NKX2.2, and PAX6).
Furthermore, isolated islet-epithelial clusters treated with ATRA led to significantly
increased NGN3 and insulin in these clusters, indicating that endocrine as well as β-cell
commitment is regulated by retinoic acid (Li et al. 2014). In tandem with the ATRA
treatment, this study found that both the reduction of ALDH1A1 expression and
inhibition of ALDH1A1 activity led to a reduction of insulin+ cells in these islet clusters
(Li et al. 2014). In summary, the results from this study established the necessary role of
ALDH1 and retinoic acid in the development of endocrine cells throughout pancreatic
development.
Additional studies have also focused on the contributions of ALDH and retinoic acid
activity towards endocrine cell commitment by examining in vivo activity. Examination
of the developing human pancreas found similar results seen in Li et al. (2014), where
ALDH1A1 gene expression occurred parallel to detected Insulin expression and was
particularly high during later developmental stages (Ostrom et al. 2008). Furthermore,
insulin+ cell development from the endoderm is controlled by retinoic acid in zebrafish
models (Stafford et al. 2006), suggesting that the role of retinoic acid in endocrine cell
development is conserved throughout animal models. The mesenchymal cells of the
pancreas are necessary for establishing its architecture, and have also been shown to play
a role in promoting transcription factors needed for endocrine cell fate (Landsman et al.
2011). Examination of the developing murine pancreas shows high levels of Aldh1a2 in
dorsal bud mesenchymal cells that subsequently affects Pdx-1 expression and endocrine
cell formation, revealing that retinoic acid production from other cell types in the
pancreas can affect islet development (Tulachan et al. 2003, Martin et al. 2005).
Embryonic stem cell studies conducted using hESCs have provided an important in vitro
source for the examination of pancreatic fate commitment and subsequent islet
development. Retinoic acid treatment of ESCs has repeatedly resulted in endoderm
differentiation and expression of PDX-1 (Micallef et al 2005, Shim et al. 2007,
Serafimidis et al. 2008, Johannesson et al. 2009, Nostro et al. 2011), and the continued
differentiation of retinoic acid-treated hESCs can lead to the production of cells positive
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for Insulin as well as inhibition of hepatic precursors from the definitive endoderm
population (Cai et al. 2010), supporting the results seen during in vivo research.

1.8.2

Exocrine Fate

The exocrine portion of the pancreas is responsible for the release of digestive enzymes
into the duodenum and arises from cells of the duodenum that retain expression of the
pancreatic transcription factor Ptf1a (Kawaguchi et al. 2002). Current information on
ALDH activity in regard to exocrine tissue development is limited, but studies have been
conducted on the effects of retinoic acid on exocrine tissue. Treatment of murine
embryonic pancreata with 9-cis RA reduces the percentage of amylase-expressing cells
(Kobayashi et al. 2002), and similar results were seen when using ATRA on murine
embryonic pancreata of a similar age (Shen et al. 2007). These results show that retinoic
acid production in the pancreas largely inhibits the development of the acinar tissue, and
suggests that ALDH activity is antagonistic of exocrine development. However, an
increase in amylase tissue has been reported in developing murine pancreata treated with
ATRA (Kadison et al. 2001), indicating that the role of retinoic acid in acinar
development may be more complex than what is reported.
Ductal structures within the pancreas are closely tied to the exocrine portion due to their
role of transporting digestive enzymes secreted from acinar cells, but are also associated
with giving rise to islet precursors during pancreatic development (Bouwens et al. 1997).
ALDH expression has been observed in adult murine ductal cells that make close contact
with acini (Rovira et al 2010) and is highly associated with ductal cells in the developing
human fetal pancreas (Li et al. 2014), suggesting a possible progenitor pool in ductal
cells. Although the presence of ALDH has been demonstrated in ductal cells, there is also
reported information regarding the effects of retinoic acid on ductal cell development. 9cis RA gives rise to increased ductal cells in murine embryonic pancreata (Kadison et al.
2001). Further analysis demonstrated that mesenchymal tissue is needed for 9-cis RAinduced ductal formations in the pancreas, due to the expression of RARs in this tissue
type (Kadison et al. 2001, Kobayashi et al. 2002). However, there are conflicting results
regarding the use of ATRA to promote ductal differentiation in murine embryonic

26

pancreata, with results showing promotion (Tulachan et al. 2003) and suppression (Shen
et al. 2007) of ductal cell development. Overall, current available research examining
retinoic acid treatment (notably 9-cis RA) indicates that it stimulates ductal cell
formation.
Pancreatic stellate cells (PSCs) are characterized to be in either an unactivated quiescent
stage or an activated stage that can produce extracellular matrices for repair (Apte et al.
2012). PSC quiescence is stimulated with retinoic acid treatment (Froeling et al. 2011),
and proliferation of stellate cells and production of the extracellular component collagen
from these cells are inhibited with ATRA and 9-cis RA treatments, implying that ALDH
activity restricts the activated cell type (Jaster et al. 2003, McCarroll et al 2006).

1.9 Rationale, Objective, and Hypothesis
Although ALDH activity has been extensively studied in neoplastic stem cells and in
stem cells from other sources (ex: hematopoietic stem cells), limited research has been
conducted on ALDH and its role in β-cell differentiation during human fetal pancreas
development. Our lab recently looked at ALDH co-localization with TF- and hormoneexpressing cells in the whole human fetal pancreas during early 1st trimester (10 to 11
weeks of fetal age) and late 2nd trimester (20 to 21weeks of fetal age) of pregnancy. The
results demonstrated high co-localization of endocrine cell TFs and hormones with
ALDH+ cells during development, leading to the conclusion that ALDH+ cells are
important for endocrine cells throughout early and late human pancreatic development
(Li et al. 2014). However, this previous study did not examine prospective sorted ALDH
populations of the human fetal pancreas and characterize their markers and TFs in vitro
and in vivo. Therefore, this project set out to separate ALDH populations from the
developing human pancreas and assess their abilities to produce β-cells in vitro and in
vivo. This thesis examined high (ALDHhi) or low (ALDHlo) ALDH populations in the
developing human pancreas at 18 to 22 weeks of fetal age, and characterized the
expression of putative stem cell markers and TFs in the sorted cells. Culture allowed for
in vitro analysis of TF expression during expansion, while transplantation of sorted cells
provided in vivo analysis of differentiation and maturation.
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Objective
To characterize the transcription factors (TFs) and putative stem cell markers in purified
cell populations with high ALDH activity (ALDHhi) or low ALDH activity (ALDHlo)
sorted cell populations in the developing human fetal pancreas, and to examine their
phenotype in vitro and in vivo.

Hypotheses
1. ALDHhi cells denote a progenitor pool in the developing human pancreas.
2. ALDHhi cells express factors indicative of commitment to the endocrine cell fate, and
can give rise to endocrine cell populations in vitro and in vivo.

Specific Questions
1. Do CD133, CD34, or CD117 co-localize exclusively with the ALDHhi populations in
dissociated human fetal pancreatic cells?
2. Does the ALDHhi sorted population contain TFs necessary for endocrine cell
development?
3. Could ALDHhi cells maintain their phenotypes during culture in vitro?
4. Could cultured ALDHhi cells give rise to islet-like cell clusters?
5. Does the subcutaneous transplantation of ALDHhi sorted cells, wrapped in fibrin gel,
enhance differentiation towards the endocrine cell type in nude mice?
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Chapter 2 – Materials and Methods
2.1

Fluorescence-activated cell sorting

2.1.1 Pancreas Tissue Dissociation
Human fetal pancreata (18 to 22 weeks of fetal age) were obtained based on the approved
protocol from the Health Human Sciences Research Ethics Board at Western University
(Appendix A), in accordance with the Canadian Council on Health Sciences Research
Involving Human Subjects guidelines. Fetal age is assigned two weeks later than the
gestational age (based on the menstrual cycle), to account for the two weeks of preovulation that precede conception. Pancreata were carefully dissected by removing all
surrounding non-pancreatic tissue, and then digested with a dissociation buffer (1x
Hank’s Balanced Salt Solution (HBSS) [Sigma, Oakville, ON, Canada]; 25 mM HEPES
[Sigma]; DNase I [Roche, Mississauga, ON, Canada]) containing collagenase V (1
mg/ml) (Sigma) in a water bath at 37°C for 30 minutes (Al-Masri et al. 2010). To inhibit
the active enzyme, dissociated samples were washed three times with cold wash buffer
(1x HBSS (Sigma); NaHCO3; Soybean Trypsin Inhibitor (STI); Bovine Serum Albumin
(BSA); Pen/Strep; Fungizone). To prepare pancreatic single cell suspensions, the samples
were further treated with 0.25x Trypsin-EDTA (Mediatech Inc., Manassas, VA) and
incubated again at 37°C for 5 minutes. Confirmation of single cells was achieved by
examining the sample using an inverted light microscope (Leica DM IL; Leica
Microsystems, Bannockburn, IL, U.S.A.). Due to time constraints, cells were kept at 4°C
overnight in CMRL-1066 media (Mediatech Inc., Manassas, VA) with 10% fetal bovine
serum (FBS) (Life Technologies Inc., Burlington, ON, CA) for cell sorting the following
day at the London Regional Flow Cytometry Facility, Robarts Research Institute.

2.1.2 Aldefluor and fluorophore-conjugated antibody staining
Pancreatic single cells were centrifuged to remove CMRL-1066 media and then
suspended in Aldefluor buffer (Stem Cell Technologies Inc., Vancouver, BC, CA). Cell
viability was examined using 0.2% trypan blue (Gibco, Life Technologies) staining with
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the automated Cellometer T4 cell counter (Nexcelom Bioscience, Lawrence, MA,
U.S.A.). Viability ranged between 80% to 90% and the total number of live cells was
between 6 x106 and 1 x107 cells per pancreatic single cell preparation. Fluorophore
Minus One (FMO) control tubes were set up as negative controls for all fluorophores
used, and were prepared with approximately 100,000 viable cells from the bulk
population. Aldefluor reagent (StemCell Technologies) was applied to detect the
intracellular activity of ALDH. The cell population was incubated at 37°C for 30 minutes
in order for ALDH to convert the fluorescent BODIPY-aminoacetaldehyde (BAAA) in
the Aldefluor reagent to BODIPY-aminoacetate (BAA), a negatively charged anion
trapped within the cell (Storms et al. 1999, Balicki. 2007). The Aldefluor FMO control
tube was treated with DEAB to inhibit ALDH activity and BAAA conversion.
Fluorophore- conjugated antibodies listed in Table 2.1 were also used to examine surface
stem cell marker populations (Hess et al. 2004). CD235a antibodies were used to remove
erythrocytes from the sorted populations and prevent inaccurate cell population
representation. Cells were incubated at 4°C for 30 minutes after antibody application.
The viability marker 7-AAD (BD BioSciences, Mississauga, ON, CA) was added to each
tube before sorting the cells in order to mark live versus dead cells within the final
populations. Cells were stored on ice to retain Aldefluor fluorescence until the time of
sort.

2.1.3 Fluorescence-activated cell sorting procedure
Prepared cells were sorted using the FACSAria III Cell Sorter (BD Biosciences, San
Jose, CA, U.S.A.), and analyzed using FACSDiva software (BD Biosciences). FMO
control tubes were used to properly gate the cell populations marked with each
fluorophore. The sample tube was sorted into two of the following populations: 1)
ALDHhi and ALDHlo populations; or 2) cell surface markerhi/ALDHhi or ALDHlo, and
cell surface markerlo/ALDHhi or ALDHlo populations.
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Table 2.1: List of antibodies used for fluorescence-activated cell sorting
Antibody
Mouse anti-human CD34 BV-

Dilution

Company

2 µl/ 1 x107

BioLegend Inc., San Diego, CA, US

2 µl/ 1 x107

BioLegend Inc., San Diego, CA, US

4 µl/ 1 x107

Miltenyi Biotec Inc., Auburn, CA, US

2 µl/ 1 x107

Miltenyi Biotec Inc., Auburn, CA, US

8 µl/ 1 x107

Miltenyi Biotec Inc., Auburn, CA, US

conjugated
Mouse anti- human CD117 PEconjugated
Mouse anti-human CD133 APCconjugated
Mouse anti-human CD133 PEconjugated
Mouse anti-human CD235a PerCPVio700-conjugated
Mouse anti-human CD235ab APCconjugated

2 µl/ 1 x107 BioLegend Inc., San Diego, CA, US
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2.2

Histological Analysis of Cell Populations

2.2.1 Paraffin Block Preparation of Sorted Cell Samples
Sorted cells were washed in PBS and fixed in 4% paraformaldehyde (PFA) (Fischer
Scientific Company, Ottawa, ON, Canada) at 4°C overnight. The cell pellet was
embedded in 2% agarose gel and then placed in cassettes for paraffin embedding as
previously described (Lyttle et al. 2008). The processing procedure involved the
following steps using an automated tissue processing machine (Shandon Citadel™ Tissue
Processor, Thermo Electron Corporation; Waltham, Massachusetts, USA): 1) dehydration
baths with increasing ethanol concentration (70% to 100%); 2) toluene baths; and 3)
paraffin wax baths. The processed samples were embedded in paraffin-filled molds and
fixed on a cold plate using an embedding machine (Thermo Shandon Histocentre 2,
Thermo Scientific, Pittsburg, PA, U.S.A) to make paraffin blocks.

2.2.2 Immunofluorescence Staining
Paraffin blocks were sectioned using a microtome (Leica RM2245, Leica Biosystems) at
4µm, and set aside to warm overnight. Removal of all paraffin from slides was done in
xylene baths, and cells were rehydrated in baths of decreasing ethanol concentration
(from 100% to 70%). For the staining of transcription factors, slides were pretreated in
either a citrate antigen retrieval solution (pH 6.0) or a trypsin-EDTA antigen retrieval
solution (pH 8.9) for heat-induced antigen retrieval of fixed epitopes (Cattoretti et al.
1993). Blocking solution with 10% goat serum was applied in order to block the nonspecific adhesion of antibodies. A list of primary antibodies used in this study is shown in
Table 2.2, and slides were incubated overnight at 4°C after primary antibody application.
Fluorescein isothiocyanate (FITC) and tetramethyl rhodamine isothiocyanate (TRITC)conjugated secondary antibodies (JRL; West Grove, PA, U.S.A.) reactive to the primary
antibody species were diluted (1:50 dilution) and incubated at room temperature for 1
hour. Cell nuclei were counter-stained by 4’,6-diamidino-2-phenylindole (DAPI) (10
mg/mL) (Sigma), and the slides were mounted with a cover slip using mounting medium
(Dako, Burlington, ON, CA). Fluorescent staining signals were examined using a
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fluorescent microscope (Leica DMIRE2; Leica Microsystems) and analyzed using the
Image ProPlus software (Media Cybernetics Inc., Rockville, MD, U.S.A.). The cell
counter program in the Image ProPlus software (Media Cybernetics Inc.) was used to
quantify the total number of cells positive for the examined antigen, and this was
normalized to the total number of cells per section and expressed as percentage.
Secondary antibody was excluded from staining for negative controls.
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Table 2.2: List of primary antibodies used for immunofluorescence staining
Primary Antibody

Dilution

Company

Mouse anti-ALDH

1:100

BD Biosciences, Mississauga, ON, CA

Rabbit anti-CD31

1:50

Santa Cruz Biotechnology Inc., CA, US

Rabbit anti-CD34

1:50

Santa Cruz Biotechnology Inc., CA, US

Rabbit anti-CD117

1:50

Santa Cruz Biotechnology Inc., CA, US

Rabbit anti-CD133

1:100

Biorbyt Ltd., Cambridge, U.K.

Rabbit anti-CK19

1:100

Abcam Inc., MA, USA

Mouse anti-CK19

1:50

Dako Canada Inc., Burlington, ON, CA

Rabbit anti-E-cadherin

1:50

Abcam Inc., MA, USA

Mouse anti-Glucagon

1:800

Sigma-Aldrich, Oakville ON, CA

Rabbit anti-Glucagon

1:50

Santa Cruz Biotechnology Inc., CA, US

Mouse anti-HMS

1:100

Millipore Canada Ltd., Etobicoke, ON, CA

Mouse anti-Insulin

1:800

Sigma-Aldrich, Oakville ON, CA

Rabbit anti-Insulin

1:50

Santa Cruz Biotechnology Inc., CA, US

Mouse anti-ISL1

1:100

DSHB, Iowa City, IA, US

Mouse anti-Ki67

1:100

BD Biosciences, Mississauga, ON, CA

Mouse anti-NGN3

1:100

DSHB, Iowa City, IA, US

Mouse anti-NKX2.2

1:100

DSHB, Iowa City, IA, US

Mouse anti-NKX6.1

1:100

DSHB, Iowa City, IA, US

Rabbit anti-PAX6

1:50

Santa Cruz Biotechnology Inc., CA, US

Guinea Pig anti-PDX-1

1:800

Dr. Wright, University of Vanderbilt, US

Rabbit anti-PDX-1

1:800

Dr. Wright, University of Vanderbilt, US

Mouse anti-SOX9

1:100

Abcam Inc., MA, USA

Rabbit anti-SOX9

1:50

Santa Cruz Biotechnology Inc., CA, US

Mouse anti-Vimentin

1:100

DSHB, Iowa City, IA, US

Rabbit anti-β-catenin

1:500

Millipore Canada Ltd., Etobicoke, ON, CA
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2.3

Quantitative Real-time Reverse Transcriptase
Polymerase Chain Reaction (qRT-PCR)

2.3.1 RNA Isolation
ALDHhi and ALDHlo cells gathered immediately after sort and expanded culture were
washed with sterile PBS. The cell pellets were lysed in cell lysis buffer using the
RNAqueous-4PCR kit (Life Technologies) according to the manufacturer’s instructions.
In brief, the cell lysate was vortexed intermittently to break up cells and then treated with
64% ethanol. RNA was collected using a collection filter and washed with wash buffer
(Life Technologies), and heated elution solution (Life Technologies) was used to collect
the RNA from the filter. DNAse buffer (Life Technologies) and DNAse (Life
Technologies) were added to the elution solution sample to eliminate DNA
contamination, and samples were incubated at 37°C for 30 minutes. The isolated RNA
solution was stored at -80°C prior to reverse transcription. RNA concentrations were
measured using 250 µL of DEPC H2O and 1 µL of RNA sample, then analyzed using a
Multiskan Spectrometer (Thermo Scientific). RNA samples with a concentration higher
than 0.1µg/µL were used for reverse transcription. The quality of the RNA was checked
by running samples on a 1% agarose gel with ethidium bromide, and confirmed with the
visual observation of 28S and 18S bands.

2.3.2 Reverse Transcription and cDNA Synthesis
RNA samples were heated with the addition of random hexamers (3000 ng/mL), Oligo
dT, and DEPC H2O at 60°C for 5 minutes and 4°C for 5 minutes using the GeneAmp
PCR System 2400 (Applied Biosystems Inc., Foster City, CA, U.S.A.). The master mix
(4 µL of 5x buffer, 2 µL of DTT, 2 µL of 10 mM dNTPs, and 0.5 µL RNAsin) was added
to each RNA sample and then centrifuged for 30 seconds. The samples were then heated
on the GeneAmp PCR System (Applied Biosystems) at the following temperatures: 42°C
for 90 minutes, 94°C for 5 minutes, and 4°C for 60 minutes. SuperScript® II Reverse
Transcriptase (Invitrogen, Burlington, ON, Canada) was added to each sample while in
the PCR System at 42°C. A final concentration of 6 µg/ 80 µL for each sample was
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achieved by diluting with sterile H2O. The cDNA samples were then stored at -20°C prior
to qRT-PCR reactions. Negative control samples were generated by excluding RNA
during the reaction.

2.3.3 qRT-PCR Measurements
Each well for the real-time reaction was prepared using the following: 3 µL of sterile
H2O, 0.5 µL forward primer, 0.5 µL reverse primer, 1 µL cDNA sample, and 5 µL SYBR
Green Master mix. The list of primers used and the annealing temperatures are listed in
Table 2.3. Negative template controls were used to verify primer specific amplification,
and prepared by substituting the primer volume with sterile H2O. After adding the
appropriate volumes, the reaction wells were mixed and loaded on to the Bio-Rad CFX
Connect™ real-time PCR detection system (Bio-Rad Laboratories Canada Ltd.,
Mississauga, ON, CA) and analyzed using the CFX Manager software (Bio-Rad). The
melting curves were used to indicate if the qRT-PCR assays had amplified target
sequences, and relative gene expression was analyzed using the comparative CT method
(2-ΔΔCT) (Schmittgen et al. 2008) and the housekeeping gene 18S.
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Table 2.3: List of primer sequences used in qRT-PCR analysis

Primer

Accession
Definition

INSULIN NM_000207.2

Sequence 5’- 3’
(Sense/Antisense)

TCA CAC CTG GTG GAA GCT CTC TA

Fragment
Size (bp)

Annealing
Temperature
(oC)

179

56.9

158

59.3

335

56.6

153

56.0

340

57.2

151

55.8

ACA ATG CCA CGC TTC TGC AGG GAC

NGN3

NM_020999.3

AGC CGG CCT AAG AGC GAG TT
TTG GTG AGC TTC GCG TCG TC

NKX6.1

NM_006168.2

AGA CCC ACT TTT TCC GGA CA
CCG CTG CTG GAC TTG TGC TT

PDX-1

NM_000209.3

CTC CTA CAG CAC TCC ACC TTG
CCG AGT AAG AAT GGC TTT ATG

SOX9

NM_000346.3

ACA AGA AGG ACC ACC CGG ATT A
AGC TCG CCG ATG TCC ACG TCG C

18S

NR_003286.2

GTA ACC CGT TGA ACC CCA TTC
CCA TCC AAT CGG TAG TAG CG
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2.4

Cell Culture Experiments

2.4.1 Examination of Extracellular Matrices on Sorted Cells
In order to examine which extracellular matrix preparation best promoted the viability of
ALDHhi cells, a modified protocol used in Krishnamurthy et al. (2008) was implemented.
Tissue culture plates (96 well, Falcon BD Beckson Dickson) were coated with 5 µg/mL
of the following matrices at room temperature for 1 hour: control (1% BSA solution),
Fibronectin, Laminin, Collagen I, and Collagen IV (BD Biosciences). ALDHhi cells were
plated on top of wells coated with matrices at a density of 1 x104 cells/ well in 100 µL of
DMEM/ F12 + 10% FBS (Life Technologies) media. Cell viability was measured at 24
hours and 5 days by treating the well with 100 µL of fresh DMEM/ F12+ 10% FBS
media and 10 µL of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT, Sigma) reagent (5 mg/mL), then incubating the samples for two hours at 37°C in
the tissue culture incubator. The MTT positive viable cells (per well) were imaged using
an inverted light microscope (Leica DM IL; Leica Microsystems) and analyzed with
Image ProPlus software (Media Cybernetics Inc). Quantification of the number of viable
cells was conducted by selecting five consistent fields in each well, and counting the
number of MTT positive cells normalized to the total number of adhered cells per
experimental group. Data were expressed as a percentage of viable cells with 3
experimental replications/group treatment.

2.4.2 Expansion Culture of ALDHhi and ALDHlo Cells
Based on the optimal viable cell results from ECM culture tests, the expansion culture
was performed on the collagen I matrix coated culture plate. Sorted ALDHhi and ALDHlo
cells were expanded on collagen I coated 12-well tissue culture plates with 1 mL DMEM/
F12 + 10% FBS (Life Technologies). Media was changed every 48 hours and cells were
passaged once wells were 90 to 95% confluent. To examine expanded cell phenotype,
cells were harvested for RNA extraction and histological analysis during expansion at
different passages.

38

2.4.3 Differentiation Culture of ALDHhi and ALDHlo Cells
Passaged cells from ALDHhi and ALDHlo sorted cell expansion were plated in 12-well
plates and cultured with 1mL of serum-free differentiation media (Gershengorn et al.
2004, Wu et al. 2010) in order to examine whether these cells could differentiate into
endocrine cells. The cell cluster formation was monitored at 0 hours, 36 hours, and 7 days
using an inverted light microscope (Leica DM IL; Leica Microsystems). Clusters were
then collected for RNA extraction and histological analysis at day 7 of the culture.

2.5

Transplantation of Sorted Cells in Nude Mice

The transplantation of sorted cells was conducted to examine the effects that an in vivo
environment had on the differentiation of ALDHhi sorted populations to endocrine
lineage. Immediately after cell sorting, ALDHhi and ALDHlo cells were embedded in 100
µL of fibrin in a 96-well plate to form a 3D gel (Riopel et al. 2013) and cultured with 100
µL of Epicult-C plus 10% FBS media (StemCell Technologies, BC, Canada). After 24
hours of culture, ALDHhi or ALDHlo cells in fibrin gels were fixed in 4% PFA,
embedded in 2% agarose gel, and processed in paraffin blocks for histological analysis.
Additionally, ALDHhi or ALDHlo cells cultured overnight in fibrin gels were
subcutaneously transplanted to nude mice, and an empty fibrin gel served as a negative
control group. In brief, 8 week-old male nude mice were anesthetized with isoflurane and
either empty gels or gels containing 24 hours cultured ALDHhi or ALDHlo cells were
implanted subcutaneously. Mice were sacrificed at 1 week post-transplantation, where
grafts were harvested for histological analyses. Animal work was performed using
protocols approved by the Animal Use Subcommittee at the University of Western
Ontario in accordance with the guidelines of the Canadian Council of Animal Care
(Appendix D).

2.6

Statistical Analysis

Data are expressed as mean ± SEM. Statistical analysis between ALDHhi and ALDHlo
groups for all FACS and qRT-PCR experiments were done using a two-tailed paired
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Student t-test using GraphPad Prism program (Version 5.0c, GraphPad Software Inc., La
Jolla, CA, USA). Immunofluorescence analysis was performed using two-tailed unpaired
Student t-tests to account for the use of unpaired sorted groups in these experiments.
Statistical significance of analyzed data was achieved at p<0.05.
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Chapter 3 -Results
3.1 FACS analysis for ALDHhi and ALDHlo groups
To isolate the ALDHhi cell population in the developing human fetal pancreas,
fluorescence-activated cell sorting (FACS) analysis by the FACSAria III Cell Sorter (BD
Bioscience) was performed. Before cell sorting, the cell viability and cell diameter was
examined using the automated Cellometer T4 cell counter. The bulk dissociated cells
demonstrated high viability (82.42 ± 2.11%), determined by trypan blue staining, and
consistent cell diameter size (9.0 ± 0.1 µm). The average total live cell population was
approximately 8.27 x106 cells per dissociated human fetal pancreas. Viable dissociated
human fetal pancreatic cells were first gated (isolation of populations of interest) using
the fluorescent viability dye 7-aminoactinomycin D (7-AAD) (Figure 3.1A), and dead
cells (7-AAD+) were discarded during cell sorting. Erythrocyte removal from the sorted
cell tubes was completed by gating out cells that stained positive for the erythrocyte
surface marker CD235a (Glycophorin A) (Figure 3.1B). Sorted cell populations were
verified based on cell size (Forward Scatter Plot, FSC) and cell internal complexity (Side
Scatter Plot, SSC) (Figures 3.1C). Separating Aldefluor-expressing cells from the viable
bulk cell population was done by using the DEAB negative control to represent the
ALDHlo population during Aldefluor fluorescence gating (Figure 3.1D, E). The purity of
the ALDHhi (94.63 ± 0.60%) and ALDHlo (99.67 ± 0.15%) sorted populations was
confirmed analyzing their Aldefluor expression. Viable cells after sorting largely
belonged to the ALDHhi sorted population (65.87 ± 3.54%), compared to the ALDHlo
population (28.37 ± 3.50%) (p<0.001; Figure 3.1F).
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Figure 3.1 Isolation of viable cell populations using fluorescence-activated cell
sorting
(A) Removal of non-viable (7-AAD high) cells using gating during cell sorting. (B)
Erythrocyte removal from the final sort population labeled by the cell surface marker
CD235a antibody. (C) Single cell population based on cell size (Forward Scatter plot,
FSC) and cell internal complexity (Side Scatter plot, SSC). (D) Separation of the sorted
ALDHhi and ALDHlo pancreatic populations, using Aldefluor fluorescence gating to
isolate ALDH activity. (E) ALDH inhibitor diethylaminobenzaldehyde (DEAB) was used
as a negative control in conjunction with Aldefluor to set the population separation
between ALDHhi and ALDHlo cells. (F) Quantification of ALDHhi and ALDHlo viability
in the final sorted population. ALDHhi cells, green; ALDHlo cells, blue; non-viable and
excluded cells, grey population. Data are expressed as mean ± SEM and were analyzed
using paired t-tests (n=15 sorted pancreata/group). *** p<0.001 vs. ALDHlo sorted
population.
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3.2 Characterization of Stem Cell Surface Markers in Sorted
ALDHhi and ALDHlo populations
The putative stem cell surface markers CD133, CD34, and CD117 expression have
previously been demonstrated on a variety of stem cell lineages. Therefore, these cell
surface markers were analyzed during FACS to determine their co-localization
frequencies in the sorted populations. CD133+ cells were present in both ALDHhi and
ALDHlo sorted populations, yet CD133 had significantly higher expression in ALDHhi
cells (65.82 ± 4.58%) when compared to ALDHlo sorted cells (8.15 ± 3.28%) (p<0.05,
Figure 3.2A,D). In comparison, the CD34+ marker was significantly higher in the
ALDHlo group (41.56 ± 2.78%) than the ALDHhi population (24.32 ± 2.86%) (p<0.05,
Figure 3.2B,D). No significant difference was detected for CD117+ expression between
the ALDHhi (12.64 ± 8.45%) and ALDHlo (10.56 ± 4.42%) populations (Figure 3.2C,D).
To examine the ALDHhi and ALDHlo sorted cells for overlapping co-localization of
surface stem cell markers, 3-colour multiparametric cell sorting analyses were performed.
Overall, equivalent but low co-localization was seen in the ALDHhi and ALDHlo
populations with CD117+/CD34+ surface markers (Figure 3.3A). Lower co-localization
of CD133+/CD34+ surface markers (Figure 3.3B) and CD117+/CD133+ surface markers
(Figure 3.3C) were also observed in both ALDHhi and ALDHlo sorted group. These
results show that the CD133+ population in ALDHhi cells and CD34+ population in the
ALDHlo cells do co-localize with other stem cell surface markers, but are largely
independent of the chosen surface markers examined in this study.
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Figure 3.2 Expression of surface stem cell markers within ALDHhi and ALDHlo
populations using FACS.
(A) Individual sorting plots for markers CD133, CD34, and CD117 (y-axis), and the costaining of Aldefluor (x-axis) for the detection of co-localizing populations. Boxed areas
on scatter plots represent separated populations based on Aldefluor and fluorophorelabeled antibody fluorescence intensity. (B) Quantification of the co-localized surface
stem cell markers with ALDHhi and ALDHlo in sorted fetal pancreatic cells. White bar,
ALDHhi group; black bar, ALDHlo group. Data are expressed as mean ± SEM and
analyzed using paired t-tests (n=4-8 sorted pancreata/group). *** p<0.001 vs. ALDHlo
sorted population.
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Figure 3.3 Co-localization between surface stem cell markers in the ALDHhi and
ALDHlo populations.
Co-expression of sorted ALDHhi (left) and ALDHlo (right) populations, and quantitative
analysis (far right) for CD117+/CD34+ (A), CD34+/CD133+ (B), and CD133+/CD117+
(C) in the sorted ALDHhi (left) and ALDHlo (middle) gated populations. Red lines
indicate co-localization of stem cell surface markers with ALDH populations. White bar,
ALDHhi group; black bar, ALDHlo group. Data are expressed as mean ± SEM and
analyzed using paired t-tests (n=4 sorted pancreata/group)

45

3.3 Analysis of TFs in sorted ALDHhi and ALDHlo populations
Commitment to endocrine, and specifically β-cell, fate in the pancreas requires a
sequence of transcription factor activation. Initial transcription factors responsible for
pancreatic progenitor fate (SOX9), pancreatic cell fate (PDX-1), and endocrine cell
commitment (NGN3) precede factors associated with islet cells (ISL1, NKX2.2,
NKX6.1, PAX6). Therefore, the analysis of transcription factor expression in ALDHhi
sorted cells is necessary to determine the commitment of these cells towards the
endocrine cell fate. qRT-PCR results, used to examine the mRNA expression of the
transcription factors, demonstrated that there was relatively higher mRNA levels of
SOX9, PDX-1, NGN3, and NKX6.1 expression in the ALDHhi cells, but statistical
significance was not reached due to a high variability between the sample groups (Figure
3.4). Using immunofluorescence staining to analyze the nuclear expression of these
transcription factors, it was found that the SOX9+ cells had higher expression in the
ALDHhi sorted cells compared to ALDHlo group (55 ± 3% vs. 14 ± 1%, p<0.001, Figure
3.5). The PDX-1+ cells also had higher percentages in ALDHhi group the ALDHlo
population (20 ± 2% vs. 2.0 ± 0.3%, p<0.001, Figure 3.5). This data, along with the
surface stem cell marker results from the previous section, could indicate that the
ALDHhi sorted population may represent a pancreatic precursor pool, but other cell fate
possibilities must be examined before concluding this. The major transcription factor for
endocrine cell fate is NGN3, and although there was increased NGN3+ labeling in the
ALDHhi group (14 ± 5%) compared to ALDHlo group (3 ± 1%), there was no significant
difference between the two cell populations (Figure 3.6). A similar pattern was observed
in NKX2.2 staining where it was insignificantly higher in ALDHhi (4 ± 1%) sorted cells,
compared to the ALDHlo (0.9 ± 0.2%) population (Figure 3.6). ISL1, an endocrine cell
marker important for insulin secretion in β-cells (Ediger et al. 2014), did not make up a
large population in the ALDHhi sorted group (3 ± 1%) but was significantly higher than
the ALDHlo (0.6 ± 0.2%) sorted group (Figure 3.6). The transcription factors PAX6 (6 ±
2% vs. 0.8 ± 0.3% in ALDHlo group, p<0.05) and NKX6.1 (12 ± 2% vs. 2 ± 1% in
ALDHlo group, p<0.01) are present in the ALDHhi sorted cells (Figure 3.7). Taken
together, higher percentages of endocrine transcription factors are expressed in the
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ALDHhi sorted cells, suggesting that the ALDHhi population could represent an early
progenitor population with low levels of endocrine specification.
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Figure 3.4 qRT-PCR analysis of ALDHhi and ALDHlo sorted cells.
mRNA expression of pancreatic transcription factors SOX9, PDX-1, NGN3, and NKX6.1
was normalized to the housekeeping gene 18S and analyzed using the comparative Ct
method (2- ΔΔCt). White bars, ALDHhi group; black bars, ALDHlo group. Data are
expressed as mean ± SEM and analyzed using paired t-tests (n=4 sorted pancreata/group)
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Figure 3.5 Pancreatic progenitor and pancreatic cell fate transcription factor
analysis in the sorted populations.
(A) Representative immunofluorescence images of SOX9 and PDX-1 (green) nuclei
staining in the sorted ALDHhi and ALDHlo populations. DAPI (blue) was used for
nuclear counter staining. White arrows indicate cells positive for TF. Scale bar: 15 µm.
(B) Quantification of SOX9+ and PDX-1+ cells in the total sorted population. White bars,
ALDHhi group; black bars, ALDHlo group. Data are expressed as mean ± SEM and
analyzed using unpaired t-tests (n=3-5 sorted pancreata/group), *** p<0.001 vs. ALDHlo
sorted population
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Figure 3.6 Analysis of transcription factors for commitment to endocrine cell
differentiation.
(A) Representative images of NGN3, ISL1, and NKX2.2 (green) staining in the ALDHhi
and ALDHlo sorted cell nuclei, labeled by DAPI (blue). White arrows indicate cells
positive for TF. Scale bar: 15 µm. (B) Quantification of NGN3+, ISL+, and NKX2.2+ cells
in the total sorted population. White bars, ALDHhi group; black bars, ALDHlo group.
Data are expressed as mean ± SEM and analyzed using unpaired t-tests (n=2-4 sorted
pancreata/group) * p<0.05 vs. ALDHlo sorted population.
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Figure 3.7 Analysis of transcription factors associated with islet endocrine cells.
(A) Representative images of NKX6.1 and PAX6 (green) staining in the ALDHhi and
ALDHlo sorted cell nuclei, labeled by DAPI (blue). White arrows indicate cells positive
for TF. Scale bar: 15 µm. (B) Quantification of NKX6.1+ and PAX6+ cells in the total
sorted population. White bars, ALDHhi group; black bars, ALDHlo group. Data are
expressed as mean ± SEM and analyzed using unpaired t-tests (n=3 sorted
pancreata/group) * p<0.05, ** p<0.01 vs. ALDHlo sorted population.
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3.4 Characterization of endocrine and ductal cells, and cell
proliferation markers in sorted ALDHhi and ALDHlo
populations
Immunofluorescence staining was used in order to characterize the pancreatic cell
composition of the sorted ALDHhi and ALDHlo groups, and to determine if one
pancreatic cell type is favoured in the ALDHhi sorted group. Insulin was found to be the
most common of the endocrine hormone markers, with significantly higher insulin+ cells
in the ALDHhi population (5 ± 1%) and nearly undetectable levels in the ALDHlo
population (0.8 ± 0.2%) (p<0.05; Figure 3.8). Somatostatin+ cells were also increased in
the ALDHhi sorted cells (3 ± 0.5%), compared to the ALDHlo sorted cells (0.7 ± 0.4%)
(p<0.05; Figure 3.8). However, there was no significant difference in glucagon+ cells
between the sorted ALDHhi and ALDHlo groups (Figure 3.8). The epithelial cell markers,
CK19 and E-cadherin, were expressed in relatively low levels in both the ALDHhi and
ALDHlo populations (Figure 3.9). The expression of β-catenin, another epithelial-linked
marker, was also examined and showed relatively similar expression levels in both
ALDHhi and ALDHlo populations (Figure 3.10). Furthermore, the mesenchymal marker
vimentin was present in the ALDHhi and ALDHlo populations, with a higher presence
demonstrated in the ALDHlo group (Figure 3.10), indicating that the ALDHhi population
is mostly devoid of mesenchymal cells. The active cell cycle marker Ki67 marks
proliferating cells, and was used to examine the proliferation of the sorted cell
populations. Interestingly, the ALDHlo population had a higher percentage of Ki67+ cells
(17 ± 1%) at the time of sort compared to the ALDHhi population (10 ± 1%) (p<0.05;
Figure 3.11). This data suggests that cells in the ALDHhi population are not active in the
cell cycle at the time of sort, and that the proliferating portion of the sorted pancreata is
largely found in the ALDHlo cells.
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Figure 3.8 Analysis of islet-specific hormone expressing cells in the sorted
populations.
(A) Representative images for insulin (β-cell), glucagon (α-cell), and somatostatin (δcell) (green) staining in the ALDHhi and ALDHlo sorted cell nuclei, labeled by DAPI
(blue). White arrows indicate positive cell staining. Scale bar: 15 µm. (B) Quantitative
analysis of hormone+ co-localization in the sorted population. White bars, ALDHhi group;
black bars, ALDHlo group. Data are expressed as mean ± SEM and analyzed using
unpaired t-tests (n=3-4 sorted pancreata/group) * p<0.05 vs. ALDHlo sorted population.
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Figure 3.9 Characterization of sorted ALDHhi and ALDHlo populations for
epithelial markers.
(A) Representative images for CK19 and E-cadherin, markers of epithelial staining
(green), stained against the total ALDHhi and ALDHlo sorted cell nuclei, labeled by DAPI
(blue). White arrows indicate positive cell staining. Scale bar: 15 µm. (B) Quantification
of CK19+ and E-cadherin+ cells in the sorted cell population. White bars, ALDHhi group;
black bar, ALDHlo group. Data are expressed as mean ± SEM and analyzed using
unpaired t-tests (n=2-3 sorted pancreata/group)
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Figure 3.10 Characterization of sorted ALDHhi and ALDHlo populations for
epithelial and mesenchymal markers.
Representative images for epithelial marker β-catenin (A), and mesenchymal cell marker
vimentin (B) (green), stained against the total ALDHhi and ALDHlo sorted cell nuclei,
labeled by DAPI (blue). White arrows indicate positive cell staining. Scale bar: 15 µm.
(C) Quantification of β-catenin+ and vimentin+ cells in the sorted cell population. White
bars, ALDHhi group; black bar, ALDHlo group. Data are expressed as mean ± SEM and
analyzed using unpaired t-tests (n=2-3 sorted pancreata/group)
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Figure 3.11 Proliferative capacity of the ALDHhi and ALDHlo sorted cell populations
using the cell cycle marker Ki67.
(A) Representative images for Ki67 proliferation in the sorted cell populations, labeled
by DAPI (blue). White arrows indicate K67+ cell staining. Scale bar: 15 µm. (B)
Quantitative analysis of Ki67+ cells in the total sorted cell populations. Data are
expressed as mean ± SEM and analyzed using unpaired t-tests (n=3 sorted
pancreata/group). * p<0.05 vs. ALDHlo sorted populations.
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3.5 Examination of sorted ALDHhi cells cultured on
extracellular matrix proteins
The selected extracellular matrices (ECM) coatings were tested to compare their
suitability for promoting viability of ALDHhi sorted cells during short-term (24 hours)
and long-term (5 days) culture conditions (Krishnamurthy et al. 2008). MTT staining was
used to examine viable adhered cells at 24 hours (Figure 3.12A) and 5 days (Figure
3.12B) after initial seeding of 1 x104 ALDHhi sorted cells/well. After 24 hours, viable
adhered cells were scattered throughout wells in the control and ECM cultured groups
(Figure 3.12A). Adhered cells cultured for a period of 5 days on control and select ECM
coatings began to demonstrate cell-cell contact, forming viable monolayers; this was
noticeable on the laminin, collagen I, and collagen IV coatings (Figure 3.12B). Fold
change for the number of viable adhered cells on each ECM coating at 5 days was
normalized to the 24 hour groups, and it was found that laminin and collagen I had a
significantly higher fold change after 5 days of culture (Figure 3.12C). These results
indicate that the laminin and collagen I coatings are ideal for the long-term promotion of
viability and expansion in sorted pancreatic cells.
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Figure 3.12 Effect of extracellular matrices on sorted ALDHhi cell viability after 24
hours and 5 days of culture.
Phase-contrast images of ALDHhi sorted cells on control- and select extracellular
matrices- coated wells at 24 hours (A) and 5 days (B) after initial seeding of wells. MTT
assays were used to confirm viability of adhered cells (dark blue). Scale bar: 100 µm. (C)
Fold change of viable adhered cells on control and select extracellular matrices at 5 days.
Data are expressed as mean ± SEM with an unpaired t-test analysis (n= 3 samples/ECM
test). *p<0.05, **p<0.01 vs. viable adhered cells at 24 hours.
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3.6 Characterization of sorted ALDHhi and ALDHlo cells
expanded in vitro
Sorted ALDHhi and ALDHlo cell populations cultured for an extended period were
analyzed to determine if the phenotype seen initially in the ALDHhi sorted cell population
was maintained during long-term culture and expansion in vitro. During extended culture
on collagen I–coated wells, the sorted ALDHhi and ALDHlo cells lost the epithelial-like
cell monolayer and began to demonstrate spindle-shaped morphology (Figure 3.13A).
Interestingly, both ALDHhi and ALDHlo cultured cells, which had demonstrated CK19
staining immediately after cell sorting, no longer expressed the CK19 marker in cultured
cells (Figure 3.13B). The epithelial marker E-cadherin was retained in ALDHhi and
ALDHlo cultured populations during expanding and passaged cultures, and the
mesenchymal cell-associated marker vimentin was present in both populations in the
expanding culture (Figure 3.13B). The presence of E-cadherin and vimentin after culture
in both populations could imply that these cell types adhered and expanded in an in vitro
environment, or that these cells had entered epithelial-to-mesenchymal transition (EMT),
similar to previously reports in islet cell cultures (Gershengorn et al. 2004). qRT-PCR
analysis of transcription factor expression in expansion culture groups showed relative
decreases of SOX9, PDX-1, and NKX6.1 in the ALDHhi cultured cells, but maintained
levels of NGN3 (Figure 3.14). The expression of INS mRNA showed similar levels
between the ALDHhi and ALDHlo cultured groups, indicating that the difference seen in
insulin expression immediately after cell sort was lost during the expanding culture
period (Figure 3.14). Immunofluorescence staining was used to confirm these results as
well as examine the change in pancreatic cell lineages of cultured cells. The cultured
ALDHhi and ALDHlo groups retained SOX9 transcription factor immunofluorescence
expression, but PDX-1, NGN3, and insulin staining were lost after expansion of the
sorted cell populations (Figure 3.15), suggesting that these cells could be heading away
from endocrine cell differentiation or that remaining cells belong to a non-endocrine
pancreatic fate.
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Figure 3.13 Morphological analysis of sorted ALDHhi and ALDHlo cell populations
after extended culture.
(A) Representative phase-contrast image of spindle-shaped cultured cells immediately (0
days, left) and 3 days (right) after passaging onto collagen I coated wells. Scale bar: 200
µm. (B) Representative immunofluorescence image for E-cadherin, vimentin, and CK19
staining on cultured ALDHhi and ALDHlo cell populations. White arrows indicate
positive cells in cultured population. Scale bar: 25 µm. (n=3-4 culture passages/group)
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Figure 3.14 Expression of pancreatic transcription factors and hormones after
expansion of ALDHhi and ALDHlo cells.
qRT-PCR analysis of SOX9, PDX-1, NGN3, NKX6.1, and INS mRNA expression in
cultured ALDHhi and ALDHlo cell populations. Data are normalized to the housekeeping
gene 18S and analyzed using the comparative Ct method. White bars, ALDHhi group;
black bars, ALDHlo group. Data are expressed as mean ± SEM and analyzed using
unpaired t-tests (n=4 cultured passages/group)
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Figure 3.15 Expression of transcription factors and the insulin hormone after
expansion of ALDHhi and ALDHlo cells.
Representative immunofluorescence images for SOX9, PDX-1, NGN3, and insulin
staining in cultured ALDHhi and ALDHlo cell populations. White arrows indicate marked
nuclei SOX9+ cells. Scale bar: 25 µm. (n=3-4 culture passages/group)
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3.7 Differentiation of ALDHhi and ALDHlo cultured cells
To examine if the expanded sorted cells could form islet-like clusters and propagate
towards β-cell fate, both ALDHhi and ALDHlo expanded cells were treated with
differentiation medium and cultured for 7 days. Phase-contrast images under the inverted
microscope demonstrated that islet-like clusters formed as early as 36 hours after
differentiation medium was added, and large, dense clusters were seen more in the
ALDHhi group after 7 days of differentiation versus the ALDHlo group (Figure 3.16). To
determine if there were any changes in transcription factors and insulin gene expression
after differentiation from cultured ALDHhi and ALDHlo cells, real-time RT-PCR analysis
was conducted. The expression of PDX-1, NGN3 and INS mRNA was relatively elevated
in the ALDHhi cell clusters, compared to the ALDHlo clusters (Figure 3.17), but no
difference was seen when statistically analyzed. Similar expression levels of SOX9 and
NKX6.1 were observed in those differentiated cell clusters (Figure 3.17).
Furthermore, immunofluorescence staining was conducted on differentiated ALDHhi and
ALDHlo cell clusters to examine phenotypic changes that resulted from cluster formation.
The weak expression of CK19, which was lost during the expansion of both cultured
groups, was noted in both ALDHhi and ALDHlo clusters (Figure 3.18). Vimentin and Ecadherin were co-stained and still present in clusters after differentiation culture (Figure
3.18), implying that the mesenchymal-epithelial cell switch occurs during the
differentiation culture in both ALDHhi and ALDHlo clusters. Weak SOX9+ staining could
also be seen in the clusters and single cells from the ALDHhi and ALDHlo differentiated
groups (Figure 3.18).
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Figure 3.16 Islet-like cluster formation during differentiation of cultured ALDHhi
and ALDHlo cells.
Representative phase-contrast images of single cells to cluster formation in cultured
ALDHhi and ALDHlo cells at 0 hours, 36 hours, and 7 days following differentiation
medium exposure. Scale bar: 200 µm.
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Figure 3.17 Expression of pancreatic transcription factors and hormone in islet-like
clusters.
qRT-PCR analysis of SOX9, PDX-1, NGN3, NKX6.1, and INS mRNA expression in
ALDHhi and ALDHlo clustered cells after a 7-day period in differentiation media. Data
are normalized to the housekeeping gene 18S and analyzed using the comparative Ct
method. White bars, ALDHhi group; black bars, ALDHlo group. Data are expressed as
mean ± SEM and analyzed using unpaired t-tests (mean ± SEM; n=3-5 cultured passages
/group)
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Figure 3.18 Morphological analysis of ALDHhi and ALDHlo clustered cells cultured
in differentiating media for 7 days.
Representative immunofluorescence staining for CK19, E-cadherin, and SOX9 (green),
and vimentin (red). Nuclei are stained by DAPI (blue). White arrows indicate CK19+, Ecadherin+, and SOX9+ cells, while yellow arrows indicate vimentin+ cells. Scale bar: 15
µm. (n=3 culture passages/group)
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3.8 Examination and analysis of transplanted ALDHhi and
ALDHlo sorted populations
Transplantation of fibrin-wrapped sorted populations into nude mice hosts was done to
determine the effect that an in vivo environment would have on the phenotype of the
ALDHhi population and differentiation towards the β-cell fate. ALDHhi and ALDHlo
sorted cells wrapped in fibrin gel were analyzed at 24 hours of culture and 1 week after
subcutaneous transplantation. It is noted that CD31+ cells were highly expressed in the
ALDHlo sorted cells compared to ALDHhi cell population (Figure 3.19A). CD31+ cells
were observed after 24h culture in fibrin gel and 1 week after subcutaneous
transplantation of the ALDHlo graft, and co-localization of the human-specific
mitochondria marker HMS with CD31 was also seen occasionally in these grafts (Figure
3.19B), suggesting that vascularization is promoted in the ALDHlo sorted population.
Both fibrin-wrapped ALDHhi and ALDHlo cell grafts were clearly observed under the
skin of the nude mice (Figure 3.19C). However, abundant vasculature formed around the
fibrin-wrapped ALDHlo cell graft and was clearly visible (Figure 3.19C, right) when
compared to the fibrin-wrapped ALDHhi cell graft (Figure 3.19C, left). Double
immunofluorescence staining for Insulin and HMS (not shown) showed no noticeable
change in co-localization or phenotype when compared to the sorted cells analyzed
immediately after sort (0 hrs), and examination of the transplanted gels for these markers
resulted in no bulk cell expression in either sorted cell group, demonstrating loss of
insulin+ cells in the gel.
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Figure 3.19 Analysis of an in vivo environment on vascularization in sorted and
transplanted cells. (A) Representative immunofluorescence images for CD31staining in
sorted ALDHhi and ALDHlo populations (0 hours). White arrows, CD31+ staining in
population. Scale bar: 15 µm. (n=2-3 sorted populations/group). (B) Representative
immunofluorescence images of CD31 (green) and HMS (red) staining in fibrin-gel
wrapped sorted cells after 24 hours in culture and 1 week after subcutaneous
transplantation. White arrow, positive staining in population. Yellow arrow, double
positive staining. Dashed lines indicate co-localization of CD31 and HMS. Scale bar: 15
µm. (C) Representative graph images of vascularization in fibrin-wrapped ALDHhi and
ALDHlo sorted cells after 1 week of subcutaneous transplantation in nude mice, graphs
outlined by dashed lines (n=5 sorted populations/group).
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Chapter 4 - Discussion
The purpose of this project was to examine the distribution of surface stem cell markers
and endocrine-specific transcription factors in the ALDHhi sorted cell populations of the
human fetal pancreas. This thesis hypothesized that ALDHhi cells represent a progenitor
cell pool in the developing human pancreas that co-localizes with other established stem
cell surface markers, expresses factors specific for endocrine cell differentiation, and
propagates an endocrine cell population in vitro and in vivo. Using FACS and
immunofluorescence staining to analyze the sorted populations, this thesis demonstrated
that ALDHhi cells co-localized with stem cell markers (CD133), transcription factors
(SOX9, PDX-1, NKX6.1), and endocrine hormones (insulin and somatostatin). Extended
culture of ALDHhi sorted cells resulted in changes to the pancreatic cell population’s
phenotype characterized immediately after sort, but differentiation induced cluster
formation and restoration of some transcription factor expression in the expanded
ALDHhi group. In summary, these results indicate that the ALDHhi cells of the human
fetal pancreas could represent a potential endocrine precursor cell pool during pancreatic
development. The following discussion section will address the five specific questions
originally introduced at the beginning of this thesis.

4.1

Do CD133, CD34, or CD117 co-localize exclusively

with the ALDHhi populations in dissociated human fetal
pancreatic cells?
Analysis of the co-localization of established surface stem cell markers with ALDHhi
human fetal pancreatic cells supports the categorization of this cell type as a precursor
cell population during development. The co-staining of Aldefluor-treated pancreatic
sorted cells against surface stem cell markers CD133, CD34, and CD117 resulted in
distinctive expression of all three surface markers on ALDHhi sorted cells. However, this
study only captures the later stages of human pancreatic development from 18 to 22
weeks of fetal age. The morphology of the pancreas in earlier stages (8 to 11 weeks of
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fetal age) is vastly different from the more mature later stage organ, as examined
previously (Lyttle et al. 2008), and the higher expression of ALDH in earlier
developmental stages (Li et al. 2014) could affect co-localization percentages with these
stem cell markers. For an accurate representation of ALDH and stem cell marker
expression in the human fetal pancreas, the pancreas should be assessed during different
developmental stages.
The highest percentage of co-localization was seen in CD133+ cells within the ALDHhi
sorted population, which correlated with our previous report in the human fetal pancreas
(Li et al. 2014). CD133+ cells in mESCs have been attributed as being not fully
differentiated (Kania et al. 2005), which supports the work that the ALDHhi population
with high CD133+ signals in the developing pancreas could represent a pool of
developmentally immature precursor cells. Due to the advanced morphology of the
pancreas at this fetal age, the CD133+ cell population could also be composed of the
established ductal structures previously reported in human fetal pancreata (Sugiyama et
al. 2007). This indicates that the ALDHhi/CD133+ sorted cell population represents a
heterogeneous pancreatic precursor pool. However, NGN3+ cells have been found in the
ductal cells that express CD133 (Sugiyama et al. 2007), implying that endocrine cells can
develop from this population. Furthermore, the percent of CD133+ cells that do not colocalize with ALDHhi cells is small, indicating that CD133+ cells are almost always found
on cells with high ALDH activity during later stages of pancreatic development. Thus,
the ALDHhi/CD133+ sorted population could denote one population for isolating a
pancreatic precursor pool that can differentiate towards endocrine cell fate, due to both
markers’ associations with islet cell production and the co-localization exclusivity seen
during late stage development.
It is noted that only ~25% of ALDHhi cells co-localized with CD34; however, a
significantly higher number of CD34+ cells are found in the ALDHlo cell population. The
association of CD34 with pancreatic progenitor cells is complex, since CD34+ cells
isolated from the murine pancreas can give rise to endothelial cells in culture (Oshima et
al. 2007). Our previous study also found that endothelial cells (identified by CD31+ cells)
did not co-localize with ALDH in the developing human pancreas (Li et al. 2014),
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suggesting that ALDHlo/CD34+ population may represent a progenitor pool for
endothelial development. It is possible that the smaller ALDHhi/CD34+ population could
be specifically related to endocrine cell differentiation, but there are not enough
published results to support this statement. Thus, further studies are needed to analyze the
composition of this population immediately after sort and examine its overlap with
known endothelial cell markers.
Unlike CD133 and CD34, the marker CD117 is relatively unchanged between the sorted
ALDHhi and ALDHlo populations. The percentage of CD117+ cells in both populations
also varied heavily between sorts. This data does not agree with our previous study where
ALDHhi cells had significantly high co-localization with of CD117+ cells compared to the
ALDHlo population (Li et al. 2014). One possible explanation for this difference is that
sampled pancreata were acquired from different age groups; the previous study used
pancreata from 13 to 22 weeks of fetal age, while this study used pancreata from 18 to 22
weeks. It is also important to note that there is a significant age-dependent decrease of
CD117 expression in certain parts of the pancreas as age increases (Li et al. 2007). This
could indicate that the later stage pancreata examined during this study no longer contain
a sortable CD117+ population, and that the ALDHhi/CD117+ sorted population, though it
could contain endocrine precursor characteristics, does not represent a significant
population of pancreatic cells at this fetal age. The ALDHhi/CD34+ and ALDHhi/CD117+
cells could be analyzed for endocrine precursor potential, but the goal of this study was to
identify surface stem cell markers that co-localized highly with ALDHhi cells during
development at this fetal age. Therefore, future studies should primarily focus on
characterizing ALDHhi/CD133+ sorted cells.
The co-localization of CD133, CD34, and CD117 on ALDHhi and ALDHlo sorted cells
was essential for examining if they exclusively co-localized with the ALDH populations,
or if there was significant overlap between the surface cell markers. When analyzing the
sorted populations, it was seen that CD117+/CD34+ cells had the highest co-localization
in both the ALDHhi and ALDHlo groups, while CD133+/CD117+ and CD34+/CD133+
cells co-localized in both groups at a lower frequency, demonstrating that none of the
selected surface stem cell markers are independent from one another in the sorted
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populations. Co-localization of these markers with the ALDHhi group has not been
previously examined in the developing pancreas, but ALDHhi/CD133+/CD34+/CD117+
umbilical cord blood hematopoietic stem cells have been shown to improve diabetic
conditions when transplanted into murine pancreata (Bell et al. 2012). This suggests that
the overlapping populations of surface stem cell markers in the sorted ALDHhi cells aid in
improving islet regeneration in damaged islets, and that ALDHhi populations with more
than one stem cell marker attributed to them could be an important cell pool for
regeneration and repair therapies in diabetics.

4.2

Does the ALDHhi sorted population contain TFs

necessary for endocrine cell development?
An established set of transcription factors necessary for endocrine cell development has
been reported in whole sections of the human fetal pancreas (Lyttle et al. 2008) and has
also been briefly examined in co-localized ALDH cells of whole fetal pancreatic tissue
(Li et al. 2014), but has not been characterized in sorted cells with ALDHhi activity. The
results from qRT-PCR analysis demonstrated relatively increased gene expression of TFs
important for endocrine cell differentiation in the ALDHhi sorted cells, which correlates
with data gathered from immunofluorescence staining; however, none of them showed
statistically significant differences between ALDHhi and ALDHlo populations at the
mRNA level. The possible reasons associated with this result may be explained due to the
following: (1) the extracted RNA concentrations from sorted single cells were lower (0.10.2 µg/µl) than those gathered from whole pancreas samples; (2) the fetal ages of
gathered samples demonstrated extreme variability due to being separated by up to four
weeks in developmental age; and (3) low cell viability after cell sorting.
Immunofluorescence staining was used to confirm the mRNA expression results and to
detect transcription factor activity in the nuclei of sorted populations. There are a number
of transcription factors that were highly expressed in the ALDHhi sorted population,
including SOX9, PDX-1, NGN3, NKX6.1 and PAX6. SOX9 was the transcription factor
with the highest nuclear presence in ALDHhi cells. The SOX transcription factor class has
been heavily associated with propagating pancreatic development (McDonald et al.
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2009). SOX9, which is up-regulated during early fetal pancreatic development and is
reduced significantly with age (McDonald et al. 2012), has been previously linked to
ALDH activity within a breast cancer-derived cell line, where treating cells with ATRA
resulted in an increase of SOX9 mRNA (Muller et al. 2010). This correlates with our
ALDH study, where DEAB treatment of isolated fetal islet-epithelial clusters reduced the
number of SOX9+ cells (Li et al. 2014). The results from previous research combined
with the results from this study indicate that SOX9 can be regulated by retinoic acid, and
that ALDH activity encourages SOX9 expression during development. It is also
important to note that the ALDHlo sorted cells also contain a small SOX9+ cell
population. The expression of SOX9 in the pancreas can be induced by factors other than
retinoic acid, notably through Fgf10-Fgfr2b signaling (Seymour et al. 2012, Belo et al.
2013). Thus, there could be a complex signaling network driving SOX9 expression,
where SOX9 activity can be dependent or independent of retinoic acid production.
Since SOX9 is a transcription factor associated with pancreatic progenitors, its high
percentage in the ALDHhi sorted population indicates that this group contains a
significant portion of precursor cells. One progenitor fate that SOX9 populations could
represent is the endocrine cell-producing ductal epithelium, due to the high number of
CD133+ cells in the ALDHhi population and the localization of SOX9 in ductal cells
during development (Sugiyama et al. 2007, Lardon et al. 2008, Kopp et al. 2011). SOX9
expression is also associated with NGN3+ and insulin+ cells as determined previously by
over-expression and knockdown of SOX9 in islet-like cell clusters, indicating its role in
β-cell development (McDonald et al. 2012). However, a higher number of PDX-1+,
NGN3+, NKX6.1+, and insulin+ cells were seen in the ALDHhi group, all previously
associated with promoting insulin+ cell-like fate (Lyttle et al. 2008). Previous research
reported an increase of the transcription factors PDX-1 and NGN3 during the
differentiation of isolated islet-like clusters from human fetal pancreata (Zhang et al.
2013), reflecting their up-regulation during the commitment towards islet cell fate in the
pancreas. This information, combined with this thesis’s results, indicates that ALDHhi
sorted cells have a higher population of cells currently differentiating towards insulinsecreting cell fate. Endocrine precursor cells tend to lose their SOX9 expression once
NGN3 activity is up-regulated (Shih et al. 2012, Belo et al. 2013), therefore the NGN3+
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population in the ALDHhi sorted group could be derived from the SOX9+ cells. Although
SOX9 expression decreases in NGN3+ and insulin+ cells in later stages of development
(McDonald et al. 2012), it is still seen in the sorted late stage cells, suggesting that
SOX9+ cells in the ALDHhi sorted group continue to contribute to the precursor cell pool.
Indeed, our previous study found that the number of insulin+ cells in isolated isletepithelial clusters was up-regulated by increasing ALDH activity and the presence of
retinoic acid (Li et al. 2014); these results parallel the SOX9 research done on the same
cell source, where increases of Insulin expression were observed with SOX9
overexpression (McDonald et al. 2012). Therefore, the higher association of insulin cells
in the ALDHhi sorted population could be promoted due to the high ALDHhi/SOX9+ colocalization in the sorted population.

4.3 Could ALDHhi cells maintain their phenotypes during
culture in vitro?
Extracellular matrix (ECM) proteins are present during structural development of the
pancreas (Hisaoka et al. 1993) and have previously been used to increase cell survival in
ex vivo culture conditions (Pinkse et al. 2006). By modifying the protocol from
Krishnamurthy et al. (2008), this study found that viability and expansion of the ALDHhi
sorted population significantly improved when cultured on laminin and collagen I coated
wells. Collagen I has been shown to improve viability, proliferation, and function of INS1 cells to maintain their cell phenotype (Krishnamurthy et al. 2008). Therefore, this study
used collagen I matrix coating for ALDHhi and ALDHlo sorted cell culture and expansion.
Interestingly, the expanded ALDHhi and ALDHlo sorted cells resulted in the formation of
spindle-like monolayers in wells. Similar monolayers were also observed in other human
islet pancreas studies (Gershengorn et al. 2004, Joglekar et al. 2009). Both ALDHhi and
ALDHlo expanded cell populations showed vimentin and E-cadherin as well as the loss of
CK19, indicating epithelial cell and mesenchymal phenotypes during culture. This could
indicate that both cultured cell populations, which demonstrated similar cell lineage
phenotypes of E-cadherin and β-catenin immediately after sort, enter epithelial-tomesenchymal transition (EMT) for the purpose of expanding the population. There is
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established evidence demonstrating that insulin-expressing cells from plated islets can
enter EMT (Gershengorn et al. 2004). Additional research also showed correlations
between the mesenchymal marker vimentin and the presence of insulin (Davani et al
2007, Cole et al. 2009). This could also account for the loss of CK19 from the cultured
populations. However, a few vimentin+ cells were present in the ALDHhi sorted
population, and these cells could have adhered and successfully expanded from the initial
seeded population, and thus the presence of vimentin may not necessarily indicate EMT.
Previous research demonstrated that β-cells from isolated islets do not enter EMT and
thus do not form mesenchymal cells (Atouf et al 2007). At least two possibilities could
account for the presence of mesenchymal markers in the cultured cell population: initial
mesenchymal cells from the original population that have expanded alongside ecadherin+ cells, or EMT as verified in differentiation experiments, where CK19+ cells
were restored in expanded cells that formed cell clusters.
Examining the mRNA expression of transcription factors in cells after extended culture
resulted in maintained NGN3 expression in the ALDHhi group. One possibility for this
could be due to the reported relationship between SOX9 and NGN3 expression in cells,
since SOX9 is still present as determined by immunofluorescence staining of the
expanded populations. Sox9 in developing murine pancreata is important for Ngn3
production, and increased Ngn3 led to down-regulated Sox9 expression (Shih et al.
2012). This could indicate that cultured cells from the ALDHhi population may continue
with commitment to the endocrine cell fate, and once again implies that the SOX9+ cells
in the ALDHhi population are primed precursors for endocrine cell differentiation.
However, the decrease in NKX6.1 and the low expression of Insulin do not indicate β-cell
specificity. Therefore, the retained presence of SOX9 after cell culture expansion could
indicate an early endocrine precursor fate that can reach islet cell specificity when treated
with differentiation factors, and this will be examined in the next section.
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4.4

Do ALDHhi cultured cells give rise to islet-like cell

clusters?
The formation of clusters was seen in ALDHhi wells when treated with media previously
applied to initiate islet-like cluster differentiation (Gershengorn et al. 2004, Wu et al.
2010), though the ALDHlo population also had cluster formation. In vitro studies in
different neoplastic populations have found increased sphere formation in ALDHhi
neoplastic cultures when compared to the ALDHlo colonies (Li et al. 2010, Soehngen et
al. 2013). The mRNA expression of transcription factors PDX-1 and NGN3, and the
hormone Insulin, in the ALDHhi cluster group suggests that the ALDHhi group is primed
towards endocrine cell differentiation after cluster formation. These changes detected at
the level of gene expression reflect the NGN3 increase in ALDHhi expanded cells, and
further reflect the importance of NGN3 as an endocrine precursor factor.
Strong immunofluorescence staining for E-cadherin and vimentin demonstrated that the
mesenchymal and epithelial cells seen during undifferentiated culture and expansion were
still present in ALDHhi and ALDHlo clusters, which corresponds to previous cluster
differentiation retaining Vimentin expression (Gershengorn et al. 2004). CK19 and SOX9
expression were seen in differentiated clusters, and the relationship between the two
during development should also be considered for these clustered cells, since SOX9+
cells in the duct have been reported as a pancreatic cell precursor pool that can contribute
to β-cell production during development (Kopp et al. 2011), and have a debated role
regarding β-cell production in injured adult pancreata (Kopp et al. 2011, Van de Casteele
et al. 2014). One interesting point to note is that SOX9 is retained at the protein level, but
there is no change between ALDHhi and ALDHlo cluster SOX9 mRNA. It can be
concluded from the expanded and differentiated data that SOX9 activity retains a
pancreatic precursor fate that has the ability to form endocrine precursor cells. This study
also demonstrated that specific culture conditions are needed to begin cell differentiation
towards endocrine fate, and that SOX9 and NGN3 expression are important, but not
sufficient, for cell commitment. Additional differentiation factors that have demonstrated
insulin+ cell production, like nicotinamide (Ye et al. 2006) and taurine (Gopurappilly et
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al. 2013), could be implemented to further stimulate these clusters towards a β-cell–like
fate.

4.5

Does the subcutaneous transplantation of ALDHhi

sorted cells, wrapped in fibrin gel, enhance differentiation
towards the endocrine cell type in nude mice?
Positive results have been reported in experiments combining a three-dimensional matrix
system to support isolated islets in vitro and in vivo (Daoud et al. 2011, HosseiniTabatabaei et al. 2013, Riopel et al. 2013), so fibrin gels were implemented in the sorted
populations to examine their differentiation potential in vivo. However, insulin staining
was not seen in the cells after transplantation. There are many possible reasons as to why
this was seen, including: 1) the low amount of cells transplanted into each graft; 2) the
transplantation time interval in the host mouse could affect the differentiation potential of
the sorted cells; and 3) the nude mice were in a normal glucose metabolic status, and thus
the drive towards insulin+ cells was not required. NKX6.1hi hESCs transplanted into mice
for a 5-month time period were able to develop into endocrine cells that restored glucose
tolerance in diabetic mice (Rezania et al. 2013), suggesting that cells may need a specific
incubation time and a diabetic situation to develop in vivo.
The most significant change observed between the sorted cell groups was the
vascularization seen in ALDHlo fibrin-wrapped sorted cells. The lack of CD31 in the
ALDHhi population has been reported in our previous study (Li et al. 2014), and this
result correlates to the current study and shows that ALDHhi cells do not promote
vascularization. CD34 is heavily associated with developing vasculature in the human
fetal pancreas, and has been shown to associate closely with developing islets (Piper et al.
2004, Sarkar et al. 2008). This is one possible reason as to why there is higher colocalization of CD34 in the ALDHlo sorted group. Therefore, further analysis should be
conducted in the ALDHlo group to determine the co-localizaton of CD34 with CD31.
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4.6

Proposed mechanism of ALDHhi cell activity in the

human fetal pancreas
By characterizing the ALDHhi sorted population and analyzing the changes seen in
culture, in clusters, and when transplanted, a mechanism for ALDH activity in the
developing human fetal pancreata is proposed below (Figure 4.1). In the developing
human fetal pancreata (18-22 weeks of fetal age), ALDHhi sorted cells represent a
CD133+ pancreatic population, with an enriched pool of endocrine precursor cells. In
contrast, the ALDHlo sorted group primarily co-localizes with the CD34 marker and
contains a higher population of cells expressing mesenchymal and endothelial cell fate
markers. Both populations contain epithelial cells, which may house the remaining ductal
and acinar tissue in the sorted cells. This information demonstrates that separation of
ALDHhi cells from the total pancreatic population isolates a unique precursor source of
cells geared towards endocrine cell differentiation.
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Figure 4.1 Proposed fate commitment of cells with varying ALDH activity during
human fetal pancreatic development. The ALDHhi developing population contains
CD133-enriched cells and a pool of endocrine precursor cells. Additionally, the ALDHlo
group expresses high levels of CD34 and represents a significant mesenchymal cell pool.
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4.7

Limitations encountered in this thesis

Although FACS has previously been performed in ALDHhi cells from different cell types,
extensive studies that solely utilize sorted ALDHhi cells from the human fetal pancreas
had not been attempted. Established protocols had to be optimized since the sorted cells
used were from a primary developing organ source. One limitation mentioned earlier was
the unavoidable prolonged incubation of dissociated fetal cells. Maintaining these cells in
this traumatized state may not have only affected the cell viability, but could have
skewed the cellular composition of the final sorted population. Previous cell sorts
demonstrated that almost half of the ALDHhi sorted group were E-cadherin+ cells (Li et
al. 2014), unlike the results of this thesis that found less than 10% of E-cadherin+ cells
were in the ALDHhi group. Furthermore, exocrine markers that have been previously
found in the human fetal pancreas were not visible in the ALDHhi or ALDHlo sorted
groups when using immunofluorescence labeling, although they were visible in ALDHhi
and ALDHlo cells of whole fetal pancreas sections (Li et al. 2014). This is another critical
limitation of this study due to the unknown percentage of ALDHhi sorted cells that
expressed exocrine markers, and challenges using ALDHhi cells as precursor markers for
endocrine fate since this population could also give rise to a significant number of
exocrine cells as well. It is possible that the cells expressing exocrine markers were
excluded from the sorts due to poor viability of this cell type. One solution for examining
the whole cell composition of the sorted pancreas is to fluorescently label specific
markers of each cell type (ex: using E-cadherin for epithelial cells) and analyze their
expression during FACS. This will be able to tell us if the populations are at least present
in the whole tissue sample, even if they are not viable sorted cells.
Due to the precise nature of cell sorting and the strict removal of all cells that do not fall
within the gated populations of interest, a large amount of cells are excluded from the
sorted population, which results in a low final cell number in both the ALDHhi and
ALDHlo sorted populations. This resulted in sample limitations for all following
experiments, including low RNA concentrations for qRT-PCR, smaller sample sizes for
immunofluorescence analysis, and a limited number of cells for transplanted fibrinwrapped sorted gels. Although the solutions for tackling these limitations are restricted, it
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is possible to increase the sorted number without including cells outside of the sorted
gates (and thus introducing cell populations that could contaminate the purity of the
marker being examined) by merging fetal pancreatic samples of similar developmental
ages. Proceeding with this introduces an additional limitation to this study: obtaining
human fetal pancreata is difficult, so merging samples reduces the sample size number
examined. It is also important to consider the unique development of each individual
pancreas and the possibility of skewing results due to this. Genetic and maternal
differences will be different between the samples, and these changes have the possibility
of strongly affecting fetal development.
Finally, challenges associated with culturing the sorted populations for expansion and
differentiation were encountered. Expanding the sorted ALDHhi and ALDHlo populations
did not maintain their phenotypes immediately seen after sort, and resulted in a loss of
ALDH activity. In addition, the transcription factor expression differences observed
between ALDHhi and ALDHlo populations was also lost, meaning that further studies
examining a larger population of these cells was not feasible without exogenous
stimulation towards differentiation. While clustering of these expanded cells allowed for
limited differentiation towards the endocrine cell fate, maintenance of these clusters was
difficult to continue. Extended exposure to the serum-free medium not only reduced cell
proliferation in previous experiments, but also increased cellular death at day 7 of
differentiation (Wu et al. 2010). Using three-dimensional matrices to house these clusters
after initial differentiation could be one method to extend cell viability and prolong cell
proliferation in vitro, since this method has demonstrated some success in past studies
(Riopel et al. 2013).

4.8

Future studies and concluding remarks

This thesis characterizes the surface stem cell markers, transcription factors, and
hormones associated with ALDHhi sorted cells of the human fetal pancreas, and examines
the maintenance of their phenotype in vitro and in vivo. The high co-localization of
ALDHhi sorted cells with cell markers, notably CD133, and their high expression of
SOX9 supports their role as a precursor for pancreatic cell fate. Analyzing endocrine-
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linked markers and concluding that the ALDHhi sorted population had a high percentage
of islet-specific transcription factors and hormone cells indicates the suitability of using
ALDH activity as a marker for isolating endocrine precursors. In addition, prolonged
culture of ALDHhi cells decreases pancreatic transcription factor expression and can
encourage EMT conditions, but stimulation of cluster formation restores endocrine
progenitor fate. Further studies should be conducted that focus on examining
ALDHhi/CD133+ cells as ideal candidates for the generation of islet cells. By
characterizing the ALDHhi/CD133+ sorted cell populations, it will be possible to compare
the percentage of islet cell transcription factors and hormone cells to the ALDHhi sorted
cells and see if the ALDHhi/CD133+ population has a specific commitment towards
endocrine cell fate. Furthermore, the ALDHhi/CD133+ cells should be examined in an in
vitro and in vivo environment to see if they display the phenotype that retains the
expression of the pancreatic progenitor marker SOX9 as well as endocrine cell markers,
allowing for the generation of islet cells. As a final point, transplantation of the
differentiated ALDHhi and ALDHlo clusters wrapped in fibrin gel would be interesting to
examine in order to see if an in vivo environment would encourage differentiation
towards insulin-producing β-like cell clusters.
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Appendix C: BioSafety Approval Form

Researcher: Dr. Rennian Wang
Biosafety Approval Number: BIO-LHRI-0046
Expiry Date: April 24, 2017

April 28, 2014
Dear Dr. Wang:
Please note your biosafety approval number listed above. This number is very useful to you as a
researcher working with biohazards. It is a requirement for your research grants, purchasing of
biohazardous materials and Level 2 inspections.
Research Grants:
This number is required information for any research grants involving biohazards. Please provide
this number to Research Services when requested.
Purchasing Materials:
This number must be included on purchase orders for Level 1 or Level 2 biohazards. When you
order biohazardous material, use the on-line purchase ordering system
(www.uwo.ca/finance/people/). In the “Comments to Purchasing” tab, include your name as the
Researcher and your biosafety approval number.
Annual Inspections:
If you have a Level 2 laboratory on campus, you are inspected every year. This is your permit
number to allow you to work with Level 2 biohazards.
To maintain your Biosafety Approval, you need to:
Ensure that you update your Biohazardous Agents Registry Form at least every three years, or
when there are changes to the biohazards you are working with.
Ensure that the people working in your laboratory are trained in Biosafety.
Ensure that your laboratory follows the University of Western Ontario Biosafety Guidelines and
Procedures Manual for Containment Level 1 & 2 Laboratories.
For more information, please see: www.uwo.ca/hr/safety/biosafety/.
Please let me know if you have questions or comments.
Regards,

Tony Hammoud
Biosafety Coordinator for Western
Support Services Building 4190
Phone: 519-661-2111 X88730
Fax: 519-661-3420

https://iwc.uwo.ca/iwc_static/layout/shell.html?lang=en&2-4.0...
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Subject: eSirius Notification - Annual Protocol Renewal

APPROVED by the AUS 2008-038-04::6
Appendix
D: Animal Use Protocol
To: rwang@uwo.ca

Date: 11/28/14 11:51 AM
From: esiriusadmin@uwo.ca, (eSiriusWebServer)

Cc: auspc@uwo.ca, auspc@uwo.ca

2008-038-04::6:
AUP Number: 2008-038-04
AUP Title: Pancreatic Beta Cell Development: The Role of the c-Kit and Integrin Receptors
Yearly Renewal Date: 11/01/2014
The YEARLY RENEWAL to Animal Use Protocol (AUP) 2008-038-04 has been approved,
and will be approved for one year following the above review date.
This AUP number must be indicated when ordering animals for this project.
Animals for other projects may not be ordered under this AUP number.
Purchases of animals other than through this system must be cleared through the ACVS office.
Health certificates will be required.

REQUIREMENTS/COMMENTS
Please ensure that individual(s) performing procedures on live animals, as described in this
protocol, are familiar with the contents of this document.
The holder of this Animal Use Protocol is responsible to ensure that all associated safety
components (biosafety, radiation safety, general laboratory safety) comply with institutional
safety standards and have received all necessary approvals. Please consult directly with your
institutional safety officers.
Submitted by: Kinchlea, Will D
on behalf of the Animal Use Subcommittee

1 of 1

2014-11-28, 12:05 PM
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Appendix E: Immunofluorescence staining for positive and negative antibody
controls. ALDHhi sorted populations were stained for: Rabbit anti-SOX9 antibody and
FITC-conjugated anti-rabbit IgG (+ve control); and FITC-conjugated anti-rabbit IgG only
(2° –ve control). Nuclei populations are stained in blue (DAPI). Scale bar, 15 µm.
Magnification, 40x
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Appendix F: Melting curves (a) and derivative melting curves (b) of qRT-PCR
products. Curves for 18S (left) and SOX9 (right) demonstrate the amplification of target
sequences in qRT-PCR reactions.
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